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ABSTRACT 
 Heart failure is a debilitating condition in which the heart cannot meet the 
metabolic demands of the body.  Chronic β-adrenergic (β-AR) stimulation causes 
pathological myocardial remodeling that leads to heart failure, in part, by promoting 
apoptosis of cardiac myocytes. Work from our laboratory has shown that β-AR 
stimulated apoptosis is dependent on reactive oxygen species (ROS), but the molecular 
targets by which ROS mediate apoptosis is not known.  
One target of ROS that may contribute to activating the apoptosis pathway is the 
sarco-endoplasmic reticulum ATPase (SERCA2). SERCA2 is responsible for moving the 
large majority of intracellular calcium in the cardiac myocyte. We have identified that 
SERCA2 can undergo oxidative post-translational modification (OPTM) of cysteine 
C674: Low ROS increase activity while high ROS decreases.  Since SERCA is the 
primary calcium transporter and is located in close proximity of the mitochondria, it is 
possible SERCA activity may affect the level of calcium in mitochondria, which in 
excess is a known activator of the intrinsic mitochondrial apoptosis pathway.  Progressive 
loss of myocardial cells in ischemia and heart failure likely contributes to the 
pathogenesis of cardiomyopathy.  
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CHAPTER ONE: Introduction 
   Heart Failure and Oxidative Stress-mediated Apoptosis 
 Heart failure (HF) is a major public health problem affecting over 5 million 
Americans. HF has an extremely high mortality rate, in excess of 50 percent within 5 
years of diagnosis 1. Risk factors for developing HF include hypertension, diabetes 
mellitus, obesity, and aging.  Despite the high prevalence and serious implications of this 
diagnosis, the mechanisms responsible for the development and progression of HF are 
not entirely known. Heart failure is characterized by the heart’s inability to pump enough 
blood and oxygen to meet the metabolic demands of the body. In a healthy individual, the 
sympathetic nervous system activates β-adrenergic (β-AR) signaling to match an increase 
in metabolic demand. β-AR stimulation increases cardiac output through a signaling 
cascade beginning with the release of norepinephrine from sympathetic neurons.  β-AR 
agonists bind to receptors on the surface of cardiac myocytes beginning a flurry of 
intracellular signaling, ultimately generating an acute increase in contractile force-
frequency.  Heart failure patients can develop β-AR desensitization, elevating levels of 
NE in the blood stream, contributing to maladaptive cardiac remodeling 2.  This 
phenomenon suggests chronic activation of β-AR signaling desensitizes myocardial β-
receptors, ultimately eliminating compensatory ionotropic reserves needed to acutely 
increase cardiac output 3.  This hypothesis led to the development of β-blockers, a 
significant improvement in therapy for HF patients 4.   
A key component of pathological cardiac remodeling is apoptosis of cardiac 
myocytes.  Although apoptosis often represents programmed cell death with the function 
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of removing unneeded cells during early development, apoptosis triggered by pathologic 
stimulus removes damaged cells from a healthy population in a manner that is less 
inflammatory than cell necrosis. Untoward apoptosis is a critical component contributing 
to cardiac decompensation in biopsied human tissue from patients with heart failure 5.  
This is due to the fact that cardiac myocytes have little regenerative capacity, therefore 
the loss of even a small percentage over time can dramatically reduce cardiac function 6.   
The exact mechanisms mediating cardiac myocyte apoptosis are not understood (figure 
1.1) 7.  Myocyte apoptosis increases mechanical strain on the remaining cells, further 
exacerbating pathological signaling 8,9.   
The Colucci laboratory discovered that β-AR stimulated apoptosis in heart failure 
is dependent on reactive oxygen species (ROS) signaling 10 and that mitochondria are a 
primary source of ROS generation within the myocardium 11. ROS are signaling 
molecules formed by enzymatic reactions within the mitochondria, primarily at complex I 
and III of the electron transport chain. However, ROS act ubiquitously within and 
perhaps outside of cells and not just within the mitochondria. Examples or ROS include 
superoxide (O-) and its derivatives hydrogen peroxide (H2O2) and hydroxyl (OH
-). 
Mitochondria also generate reactive nitrogen species including nitric oxide (NO-) and 
peroxynitrite (ONOO-) 12. The ROS share the ability to reduce double bonds present in 
nucleic acids, proteins and lipids, causing irreversible injury.  Under physiological 
conditions, inevitable mitochondrial ROS generation is balanced by endogenous 
antioxidants including superoxide dismutase, catalase, glutathione, as well as oxidant 
sensors which activate transcription of antioxidants in response to an increase in ROS 13. 
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Cardiac myocytes display a ROS concentration-dependent phenotypic response whereby 
low levels activate hypertrophic signaling while high concentrations activate apoptosis 8.  
These concentration-dependent effects are potentially a consequence, in part, of protein 
oxidation.  Oxidative post-translational modifications (OPTMs) can disrupt physiological 
signaling throughout the cell.  We are still learning which proteins can undergo OPTM, 
however it is clear that OPTM can alter normal protein activity 14.  Together, excess ROS 
generation as a consequence of maladaptive β-AR stimulation increases the likelihood 
that cardiac myocytes will undergo apoptosis and as a consequence, promote the 
progression of decompensated cardiac hypertrophy to heart failure.   
 Mitochondrial dysfunction has been identified as a pathologic risk factors for 
heart failure 15,16.   Pathological ROS generation is an important characteristic of 
mitochondrial dysfunction.  Multiple investigators have used expressing endogenous or 
exogenous antioxidants to alleviate the downstream effects of pathological ROS.  
Transgenic mouse models overexpressing catalase, an endogenous antioxidant, in the 
mitochondria or cytosol prevented mice from developing acute and chronic heart failure 
17–19. In one study, peroxisomal overexpression of catalase in transgenic mice attenuated 
chronic pressure overload-induced apoptosis 19.  However, there is evidence that each 
cardiac pathology requires a specific antioxidant targeting strategy.  For example, 
mitochondrial but not peroxisomal catalase expression ameliorated angiotensin II-
induced heart failure 20.  Together, these studies demonstrate that the HF phenotype has 
diverse pathology, increasing the biologic challenges in designing an antioxidant 
treatment for HF 21.   
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  Leading strategies for improving mitochondrial dysfunction in heart failure 
include activating and harnessing antioxidant systems, restoring mitochondrial structure, 
improving NAD/NADH redox, and modulating mitochondrial calcium through 
sodium/calcium exchange (NCX) 21.   Unfortunately, therapeutics targeting endogenous 
mitochondrial or cellular antioxidant in mice, have not yet been successful in humans 
21,22.  MitoQ and SS-3, two leading mitochondrial-targeted antioxidant therapies, are 
under investigation.  MitoQ, is a coenzyme Q derivative that is bound to a lipophilic 
cation allowing entry and accumulation in the mitochondrial matrix.  MitoQ is an 
example of a targeted antioxidant that has had some success, however its effects are 
limited by the mitochondrial redox capacity necessary for recharging MitoQ 23.  SS-31, 
also known as Bendavia or Elamipretide potentially improves mitochondrial function by 
interacting with mitochondrial cristae protein, cardiolipin 24.  In vitro studies have shown 
this interaction also inhibits cytochrome c peroxidation, improving bioenergetics and cell 
survival 25,26. Thus far, SS-31 has shown potential for treating neurodegenerative diseases 
27. Translating mitochondrially-targeted therapies from mice to humans is likely to be 
unsuccessful due to the challenge of regenerating antioxidant capacity of these exogenous 
treatments.  Oxidized forms of the treatment are unable to be reduced and instead can be 






Figure 1.1. Heart failure is characterized by reduced sympathetic tone due to ROS 
mediated maladaptive β-AR signaling.   Under physiologic conditions, an increase in metabolic 
demand activates the sympathetic nervous system, causing an acute increase in cardiac output by 
increasing myocyte contractility force and frequency (Blue Arrows).  Under pathological 
conditions, including individuals with decompensated cardiac function, sympathetic activation is 
unable to improve in cardiac output, causing excessive ROS generation, and ultimately 
pathological cardiac remodeling (Red Arrows). 
                  SERCA in the Heart 
The sarco-endoplasmic calcium ATPase (SERCA) is a sarcoplasmic reticulum  
(SR) transmembrane protein responsible for pumping calcium from the cytosol to the 
lumen of the SR by hydrolyzing ATP during muscle relaxation 28.    There are three genes 
encoding up to 14 mRNA isoforms of SERCA and the expression of each isoform is 
developmental, tissue specific or pathology dependent 29,30. SERCA2a is the dominant 
isoform located in the heart, followed by SERCA2b.  SERCA2a and 2b differ by 
replacement of the last four amino acids of SERCA2a by an additional 49 amino acids in 
SERCA2b, possibly coding for an additional SR transmembrane segment 31.     
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A reduction in SERCA activity was first discovered in HF patients in the late 
1980’s 32. Since then, multiple transgenic mouse models have enhanced our 
understanding for how SERCA activity affects the heart. Genetic disruption of both 
alleles and homozygous deficient SERCA2 mouse die early in development.  However, 
heterozygous SERCA2 knock-out (KO) mice live to term and, rather surprisingly, do not 
exhibit overt cardiac pathology 33,34. The authors of these studies attribute basal 
functionality to compensatory mechanisms such as upregulation of calcium transporters.  
Despite relatively normal basal cardiac function, SERCA2(-/+) mice display accelerated 
development of heart failure compared to control mice 35.  SERCA2(-/+) also display 
hypersensitivity to calcium overload after ischemia-reperfusion 36. The generation and 
study of a conditional, cardiac specific SERCA2 KO mouse supported these findings. 
Four weeks after inducing SERCA2 KO, less than 5% of SERCA2 protein content 
remained, and yet cardiac function is not different than control littermates 37.  These mice 
did not develop observable cardiac dysfunction until  7-weeks post induction 37.  
Myocytes isolated from conditional SERCA2 KO mice were still susceptible to β-AR 
stimulation by isoproterenol at 4 and 7 weeks after deletion, suggesting compensatory 
upregulation of  β-AR signaling at a whole organ level may be responsible for 
maintaining basal function after deletion of SERCA2 protein 38.  In summary, SERCA2 
expression appears to contribute less to cardiac function at rest than under stress, and β-
adrenergic signaling is capable of providing short term compensation for disrupted 
SERCA2 function.   
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SERCA can be regulated by phospholamban (PLN), microRNA39, post-
translational modifications including acetylation 40, sumolyation 41 and oxidative post-
translational modifications 42.  Phospholamban (PLN) is an integral membrane protein 
which regulates SERCA activity in the heart.   When PLN is phosphorylated by protein 
kinase A (PKA), SERCA activity increases 43.  SERCA has three cytosolic facing 
domains including the phosphorylation domain (P-domain), nucleotide-binding domain 
(N-domain),  and the actuator domain (A-domain) that can be exposed to intracellular 
signals including ROS 44.  SERCA2 residue C674 is the most frequently oxidized 
cysteine at physiological pH. Oxidative regulation of SERCA C674 is bidirectional, 
causing an increase or decreased in activity 45–47.  Oxidative inhibition of SERCA C674 
has been identified in senescent mice 48 as well as in models of heart failure 19.   
 
Figure 1.2. SERCA C674 oxidation can activate or inhibit enzyme activity. Cysteine C674 is 
the primary site for oxidative regulation of SERCA activity. Physiological or low concentrations 
of ROS reversibly oxidize SERCA C674 increasing enzyme activity.  Pathological or high 
concentrations of ROS irreversibly oxidizes SERCA C674, reducing or inactivating SERCA.  
However, recent studies suggest SERCA inhibition is not necessarily pathological, but possibly a 




Preliminary in vivo studies performed in the Colucci lab identified mice with 
systemic, heterozygous expression of redox-insensitive SERCA C674S 49 (SKI) to be 
resistant to pathological remodeling associated with heart failure in a chronic PO model 
(unpublished).  SKI mice maintained relatively normal systolic and diastolic function, 
whereas WT mice were mortally affected by 12 weeks of PO.  Histological analysis of 
the left ventricle confirmed SKI mice were protected from pathological remodeling at a 
cellular and molecular level as compared to WT.  Additionally, SKI mice had less 
myocyte hypertrophy and interstitial fibrosis, as well as a reduction in apoptotic signaling 
including JNK activation, as well as less cleaved caspase-3 and terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive cells (vs. WT). 
Interestingly, SKI mice developed less oxidative stress, interpreted from a reduction in 
membrane lipid peroxidation assessed by 4-hydroxynonenal (HNE) (vs. WT).  These data 
suggest SERCA C674 somehow reduces ROS generation or enhances antioxidant 
capacity in cardiac myocytes.   
 SERCA has been targeted in multiple clinical trials.  One group’s strategy was to 
increase SERCA activity in cardiac myocytes infected  with SERCA containing 
adenovirus to improve contractile function 50.  Although this study initially appeared 
successful, patients with severe heart failure did not benefit from increased SERCA 
expression in subsequent studies.  Identifying a clear role for SERCA oxidation in heart 
failure could potentially lead to a new type of therapy for heart failure.  Recent 
developments in precision electrophilic targeting, a system that identifies and yields 
potential compatible small molecules that interfere with thiol oxidation in specific 
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proteins, a promising next generation treatment strategy 51,52.  This new technology is 
rapidly expanding and may be useful in targeting SERCA C674, an approach that might 
mitigate the source of contractility dysfunction within the cardiac myocytes of heart 
failure patients.  
Mitochondrial Calcium in the Heart 
Our understanding of mitochondrial calcium has evolved with advancing imaging 
technology. Mitochondrial calcium dependent processes were first measured using 
calcium sensitive dyes that changed spectral characteristics when bound to calcium 53. 
The original dyes required microinjection and became outdated when synthetic 
fluorescent indicators that can be delivered into cells by simple incubation with 
acetoxymethyl ester (AM) derivatives were developed in the 1980’s by Dr. Roger Tsien 
54.   Starting in early 2000 the Tsien group developed genetically-encoded calcium 
indicators (GECI), which are commonly considered the gold standard for intracellular 
calcium imaging. GECI’s are fluorescent indicators utilizing aquaporin or GFP variants. 
Aquaporin based GECI’s do not require excitation as their emission is based on a 
chemical reaction, while GFP based GECI’s contain a calcium binding domain which is 
usually a calmodulin-M13 complex. Both GECI’s can be targeted to the mitochondria 
specifically by adding a cytochrome c oxidase VIII targeting sequence construct 55.   
Single fluorophore and dual fluorophore GECI have been implemented 
successfully in cardiac myocytes (FRET) (Figure 1.2).  The former includes single 
emission or ratiometric emission for newer generations 56. Single fluorophore GECI’s can 
be single-wavelength or ratiometric with varying binding kinetics, making them great 
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tools for measuring calcium transients of varying speeds in cardiac myocytes 57.  GCaMP 
is a single fluorophore GECI that has the highest signal-to-noise ratio, with read outs 
similar to FURA-2 56,58.  GCaMP indicators have been incorporated into transgenic 
mouse models and been successfully targeted to more subcellular compartments 
compared than any other GECI 56,59.  Single fluorophore GECI have limitations including 
reduced calcium sensitivity, pH-sensitivity and they are unable to reconcile myocyte 
movement which is a distinct issue when measuring calcium in cardiac myocytes. Lastly, 
quantitative measurements using single fluorophore GECI’s are limited 56. Dual 
fluorophore GECI, or FRET based GECI’s, also known as Cameleons, are ratiometric 
and therefore eliminate most of the shortcomings of single fluorophore GECI’s 60.  They 
can be used for quantitative measurements if appropriately calibrated within the specific 
cell-type they’re being used 61.  Alternatively, most researchers still use GECI for 
qualitative and not quantitative applications due to limited standardization of calibration 
protocols 56. The most significant limitation is that both fluorescent proteins are GFP 
variants, primarily CFP and YFP, which have overlapping emission spectra.  GECI’s are 
continuing to be modified to improve signal to noise background and also improve 
binding kinetics with calcium 56. Nevertheless, their existence has made it possible for 
researchers to improve calcium in vitro and in vivo calcium measurements and elucidate 




Figure 1.3. Mechanism of action for genetically encoded calcium indicators (GECI) with 
single or dual (FRET) fluorophores. Top. Single Fluorophore GECI- Calcium ions bind to 
calmodulin-M13 domain causes a conformational change, altering spectral emission.  Bottom. 
Dual fluorophore GECI (FRET) - Calcium binding to calmodulin-M13 domain causes a 
conformational shift permitting transfer of energy from donor to acceptor fluorophore. Figure 
from Oh et al.62 
 
Mitochondrial calcium entry and extrusion pathways are potential targets for 
altering cardiac myocyte metabolism and cell fate.  In order for calcium to enter the 
mitochondria, it must first move through the nonselective outer mitochondrial membrane 
(OMM) by way of the high conductance, low selectivity voltage-dependent anion channel 
(VDAC).  Calcium entry through the intermembrane space (IMM) requires transport 
through a voltage or chemically gated ion channel 63.  The primary route of calcium entry 
is through the mitochondrial calcium uniporter (MCU) 64. The genetic identity of the 
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MCU was identified in 2011, allowing for the characterization of the calcium transporter 
complex 65,66. One important finding was the identification of MICU1 and MICU1 
regulator proteins with EF-hands rendering the MCU sensitive to local changes in 
calcium within the IMM 67.  The generation of the MCU KO mouse posed many new 
questions. Surprisingly, these mice were not largely affected by the lack of MCU unless 
challenged by ischemia-reperfusion 68.  This contradicted original thoughts that the MCU 
was the only mechanism for rapid mitochondrial calcium uptake.  However, in 2005, the 
Sheu group hypothesized and provided evidence for MCU independent pathways 69.  
Their findings indicate the presence of type-1 ryanodine receptors (RyR) located on the 
mitochondrial membrane (mRyR) that forms a dyad with IP3 receptors on the SR, 
promoting mitochondrial calcium uptake.  Furthermore, this group later suggested that 
there are two types of SR-mitochondrial contacts promoting mitochondrial calcium 
uptake: mRyR with IP3 and RyR (on the SR) with the MCU. They suggested that the 
location of the mitochondria within the cell may determine which dyad is responsible for 
mitochondrial calcium 70.   
The heart is heavily reliant on mitochondria as a source of ATP.  It is estimated 
that mitochondria supply >90% of the ATP needed for contractility 21,71.  Energy 
production is initiated in the mitochondria by calcium entry and activation of three 
dehydrogenases of the Krebs cycle; pyruvate dehydrogenase, isocitrate dehydrogenase 
and α-ketoglutarate dehydrogenase 72. While calcium-mediated activation of Krebs cycle 
dehydrogenases has been known for years, a recent study suggested that calcium 
influences ATP production by directly binding to ATP synthase 73. Calcium entry is 
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coupled to energy production by calcium dependent processes but also by physically 
separating mitochondrial influx from efflux pathways. Specifically, researchers identified 
MCU calcium hot spots with close proximity to RyR receptors that appeared to be 
spatially distant from the sodium-calcium exchanger (NCLX), the primary calcium 
extrusion channel 74.  The authors hypothesized that separating calcium entry and efflux 
made energy production more efficient.  In mice overexpressing the NCLX, calcium 
signaling and oxidative phosphorylation were inhibited 74.  This study suggested that 
mitochondrial dysfunction is due in part to reduced spatial separation of mitochondrial 
entry and efflux pathways.  This is supported by the uncoupling of glycolysis and 
oxidative phosphorylation, as well as global reduction in ATP production 75,76. 
Altogether, it is likely that mitochondrial calcium contributes to the metabolic substrate 
switch that is a hallmark of heart failure. 
Both too little and too much mitochondrial calcium has been identified in in vitro 
and in vivo models of HF.  Under pathological conditions, a reduction in mitochondrial 
calcium depresses ATP production 77.  Some studies have reported low mitochondrial 
calcium due to high intracellular sodium causing energy depletion and cell death in HF 
models.  In one model, high intracellular sodium drove calcium out of the mitochondria 
via the mitochondrial NCLX, thereby decreasing pyruvate dehydrogenase activity and 
ATP production. Simiarly, cell death has also been alleviated by blocking the 
mitochondrial sodium calcium exchanger 37.  On the other hand, mitochondrial calcium 
overload has also been implicated in mitochondrial dysfunction and activation of 
apoptosis 78,79.  As mentioned previously, stimulated apoptosis is a cell death pathway 
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that removes unhealthy cells from a healthy population.  While the precise mechanism of 
calcium overload-mediated apoptosis is unknown, it is likely dependent on  cyclophilin D 
(CypD), a regulatory protein identified in the mitochondrial permeability transition pore 
(mPTP) complex 79.  This hypothesis us supported by the facts that calcium overload-
induced apoptosis is prevented in mouse myocytes lacking cyclophilin D as well as by 
pharmacological inhibition of CypD 80,81. Moreover, high levels of calcium caused mPTP 
opening in the absence of CypD, suggesting that CypD only sensitizes but does not 
activate mPTP 80. Another study found that ROS sensitizes the mPTP to opening 82,83.  In 
this model, prolonged mPTP opening and apoptosis was thwarted by “flash” ROS release 
by the mPTP, allowing calcium efflux and restoration of the mitochondrial membrane 
potential. This protective mechanism has been implicated in local ROS-induced-ROS 
signaling where local bursts of ROS between neighboring cells causes transient 
asynchronous mPTP opening to locally alleviate mitochondrial dysfunction while 
remaining mitochondria are polarized and functional 79.    
Interventions specifically targeting myocardial cell apoptosis have had poor 
efficacy.  By the time a patient has apoptosis, it is unlikely they will benefit from 
maneuver designed to inhibit subsequent cell death.  Additionally, preventing apoptosis 
can activate alternative cell death pathways including necrosis that exacerbate pathologic 
signaling and tissue injury 84.  However, it may be possible to inhibit apoptosis upstream, 
by targeting and restoring physiological mitochondrial calcium signaling heart failure 
patients 64. Potential strategies for restoring mitochondrial calcium are focused on 
inhibiting transporters such as the sodium calcium exchanger (NCX), sodium hydrogen 
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exchanger (NHE) or the sodium-glucose cotransporter (SGLT2).  Ranolazine blocks late 
inward sodium currents, thereby reducing calcium entry into the cell and potentially the 
mitochondria. SGLT2 inhibitors may reduce mitochondrial calcium overload by 
correcting cellular calcium balance 21.  Unfortunately, the effectiveness of this strategy is 
dependent on the etiology of pathology.  Additionally, these drugs are not targeted to the 
mitochondria which increases the likelihood of off target effects, compromising their 
benefits. Overall, restoring physiological mitochondrial calcium homeostasis is a 

















Figure 1.4. Physiological vs. Pathological Mitochondrial Calcium. Top. Physiological 
mitochondrial calcium uptake drives mitochondrial ATP production and antioxidant substrate 
generation. Bottom. Pathological mitochondrial calcium overload reduces the mitochondrial 
membrane potential, increases ROS generation and activates the mitochondrial apoptosis 






Sarcoplasmic Reticulum - Mitochondrial Calcium Signaling in the Heart 
Contact points between the mitochondria and SR were first identified in 1960, 
however the structural and functional importance of this area, known as the 
mitochondrial associated membrane space (MAMs), is largely unknown.  Using 
advanced microscopy techniques, multiple groups identified physical tethering between 
the SR and mitochondria 86–88 that creates a space of just a few nanometers, effectively 
compartmentalizing and concentrating cross-talk signaling between the SR and 
mitochondria. The molecular identity of proteins located within the MAM’s is cell-type 
dependent 89.  Cardiac myocytes are extremely dense, organized cells where the MAMs 
forms primarily between the junctional SR and mitochondria.  The junctional SR is 
densely populated with RyR and SERCA, 37nM away from the mitochondria 88.  
Because SERCA is located within the MAMs, and SERCA is the primary calcium 
transporter in the mitochondria, it is likely SERCA activity modulates calcium dependent 
mitochondrial processes including mitochondrial metabolism and cell fate. 
The purpose of the MAMs is not fully understood however, it is clearly a 
specialized microdomain for calcium transfer between the SR and MAM 90. The 
functional importance of MAM structure was elucidated in mice lacking the proteins 
responsible for tethering the SR to the mitochondria, mitofusin-1 (MFN1) and mitofusin-
2 (MFN2): MFN2 appears to contribute to SR-mitochondrial tethering to a greater degree 
than MFN1 91, however different conclusions have been drawn from experiments 
utilizing MFN2 KO mice.  In one study, MFN2 KO mice had a 30% decrease in SR-
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mitochondrial contact length, increased ROS production and reduced mitochondrial 
calcium, as well as a reduction in oxidative phosphorylation 91.  In a different genetically 
derived MFN2 KO mouse, the structure of SR-mitochondrial contacts were unchanged, 
however KO mice were more tolerant to calcium induced mPTP opening 92. Despite the 
difference in methodology and conclusion, both studies found MFN2 creates a 
microdomain that important for enabling calcium signaling between the SR and 
mitochondria in cardiac myocytes.  
During heart failure, increased calcium leak from the SR stimulates mitochondrial 
calcium uptake but it is uncertain whether calcium exits the SR via the RyR, the IP3 
receptor (IP3R) or both receptors. However it is important to note cardiac myocyte have a 
50-100 fold increase in RyR vs IP3R 
93. In one study, mice with constitutively active RyR 
had decreased caffeine sensitive SR calcium release and developed mitochondrial 
calcium-induced apoptosis.  This study also examined the role of IP3R receptor oxidation 
and found mice lacking the IP3R did not elicit the same mitochondrial calcium or cell 
survival phenotype 78.  If true, then blocking RyR calcium leak will attenuate 
mitochondrial calcium uptake. In support of this model, a recent study found caffeine-
sensitive SR calcium release primarily through RyR, was inversely regulated by MCU 
expression 94.   Furthermore, identification of supramolecular complex formations of 
IP3R and the mitochondrial outer membrane, non-specific channel VDAC and chaperone 
GRP75 implicates IP3R over RyR in mediating SR calcium release.   In this study, 
pharmacological activation of calcium release through IP3R but not RyR, increased 
mitochondrial calcium.  This group also showed calcium uptake into the mitochondria via 
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IP3R mediated calcium transfer led to mitochondrial depolarization 
95. In summary, 
although the route of calcium movement into the mitochondria is disputed, the 
importance of calcium signaling between the SR and mitochondria is irrefutable.   
Disruption of the MAMs has detrimental effects on cardiac myocyte function in 
vitro and in vivo 70,91,96. The SR-mitochondrial microdomain has therefore become a new 
target for therapeutic intervention 97–100.  A recent study in a neuronal model of 
Huntington’s disease showed mitochondrially-targeted antioxidant-like peptides such as 
SS-31 and MitoQ can upregulate the pro-fusion proteins, upregulate mitochondrial 
biogenesis and antioxidant regulators in neurons, reducing mitochondrial toxicity101.  
Moreover, a study evaluating the molecular basis of mitochondrial dysfunction associated 
with Mtf-2 depletion in cardiac myocytes was partially rescued by supplementation with 
coenzyme Q10, a predominantly cytosolic antioxidant as opposed to SS-31 and MitoQ 
which specifically accumulate within the mitochondria 102. Together these studies 
accentuate the importance and therapeutic potential for preserving or restoring SR-




                
Figure 1.5. The mitochondrial-associated membrane (MAM) facilitates SR – mitochondrial 
calcium signaling within cardiac myocytes.  The MAM consists of structural proteins including 
MFN1 and MFN2 which tether the SR and mitochondria, creating a microdomain approximately 
40 nm wide.  The MAM is dense with calcium channels facilitating calcium movement from the 
SR into the mitochondria.  Calcium within the MAM (red circles) can be pumped back into the 













Hypothesis and Specific Aims  
 The molecular mechanisms underlying pathological cardiac remodeling 
associated with heart failure are not fully understood.  We have previously shown that 
ROS dependent activation of the mitochondrial apoptosis pathway contributes to 
declining cardiac function, however the intracellular targets of ROS contributing to the 
decline are unknown.  ROS-mediated oxidation of the calcium handling protein SERCA 
has been reported to alter intracellular calcium signaling, potentially disrupting 
mitochondrial calcium availability.  Since SERCA is the primary calcium transporter and 
is located in close proximity of the mitochondria, it is possible SERCA activity may 
affect the level of calcium in mitochondria, which in excess is a known activator of the 
intrinsic mitochondrial apoptosis pathway. In this thesis, I seek to determine the role of 
SERCA oxidation in mediating mitochondrial calcium and potentially activation of 
apoptosis in cardiac myocytes.    
Hypothesis:  
SERCA C674 oxidation regulates apoptosis by modulating mitochondrial calcium 
content. 
Specific Aims: 
1. Investigate the role of SERCA activity and redox regulation at C674 on 
mitochondrial calcium content using a mitochondrially-targeted genetically encoded 
calcium indicator in vitro. 
To test my hypothesis, I optimized a technique for measuring mitochondrial 
calcium using an adenovirus containing a highly sensitive mitochondrially-targeted 
22 
 
calcium Cameleon probe (CAMmito).  Using this tool, I measured the effect of SERCA 
activity on mitochondrial calcium and caffeine sensitive SR calcium content in WT or a 
redox-insensitive SERCA C674S expressing ARVM.   
2. Identify functional consequences of SERCA C674 regulation on mitochondrial 
function and cell fate in vitro. 
To test my hypothesis, I subjected ARVM expressing WT SERCA or SERCA 
C674S to an oxidant challenge and measured multiple indicators of mitochondrial 

































         Materials and Methods 
2.1. Adult rat ventricular myocyte isolation and culture 
Adult rat ventricular myocytes (ARVMs) were isolated from the hearts of adult 
male Sprague-Dawley rats (175-200 g, Harlan) as we previously described 45 and 
cultured in serum-free media. In brief, hearts were excised and retrograde perfused with 
Ca2+ free Krebs-Henseleit Buffer (KH: 118 mM NaCl, 4.75 mM KCl, 1.2 mM MgSO4, 
1.2 mM KH2PO4, 25 mM NaHCO3, 48 mM dextrose, pH 7.4) at a rate of 7.5-8 
mL/minutes for 2 minutes through the aorta at 37 °C. The heart was then digested with a 
recirculating KH solution containing collagenase type II (0.14-0.15 mg/mL, Sigma) and 
hyaluronidase Type II (0.14-0.15 mg/ML, Sigma) for 17 minutes. Hearts were then 
halved, quartered, and minced into longitudinal strips. Cells from the left ventricle were 
released by shaking the tissue at 37°C in KH digestion buffer supplemented with DNAse 
(0.02 mg/mL, Worthington), Trypsin Type IX (0.02 mg/mL, Sigma), and 1 mM CaCl2 
for 25 minutes and then centrifuged for 3 minutes at 50 x g. The cells were filtered 
through a 100-μM mesh filter and allowed to settle for 10 minutes in wash buffer (50% 
KH, 50% DMEM). Cells were resuspended in DMEM (Gibco), layered over 0.0645g/mL 
BSA (Sigma) to separate ventricular myocytes from nonmyocytes, and allowed to settle 
again for 10 minutes. The cells were then resuspended in ACCT medium consisting of 
DMEM containing 0.2% BSA (Sigma), 2 mM L-carnitine (Sigma), 5 mM creatine 
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(Sigma), 5 mM taurine (Sigma), 2.5 M HEPES and 100 U/mL penicillin-streptomycin 
(Gibco). ARVMs were then plated on 35-mm (Fisher); or 4 well (LabTek) or 35-mm 
glass bottom culture dishes (MatTek) precoated with laminin (10 μg/mL Invitrogen). 
After 1 hour, the ARVMs were washed with ACCT to remove unattached cells. After 48-
72 hours in culture, ARVMs were treated with H2O2 (100 μM) at varying time points 
specified in each experiment.  
2.2. Adenoviral constructs and ARVM infection  
Adenoviral vectors encoding human SERCA2 (WT), human mutated SERCA2 
(C674S), Cameleon construct 4mtCameleon-Nano15, and Perceval-HR103 were 
constructed as previously described104. The yellow Cameleon-Nano1560 and Perceval-HR 
were purchased from Addgene. To generate the redox-insensitive SERCA mutant insert, 
mutagenesis of SERCA cysteine-674 was performed using the Stratagene mutagenesis 
kit.  To target the yellow Cameleon-Nano15 to the mitochondria, the mitochondrial 
targeting sequence with four copies of the subunit VIII of human cytochrome C 
oxidase105 was sub-cloned from the mitoD3CPV (kind gift from R.Y.Tsien) onto the 
yellow Cameleon-Nano15 as previously described 106. The inserts of SERCA 2b WT, 
SERCA 2b C674S, 4mtCameleon-Nano15 (CAMmito), and Perceval-HR were excised 
from pcDNA3.1 using PME-1 and ligated into the EcoRV site of pShuttle, under the 
cytomegalovirus (CMV) promoter. The correct direction was confirmed by enzyme 
restriction analysis as well as sequencing. This shuttle vector was cotransfected into E. 
coli with pADEasy, and the appropriate cosmids were using PAC-1 digestion then 
transfected into HEK-293 cells using calcium phosphate. The adenoviruses were 
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propagated in HEK 293 cells and purified via a double cesium chloride gradient to 
remove noninfectious empty capsids107.  The viral titer was determined using the TCID50 
method. ARVM were infected with WT SERCA (MOI = 100) or C674S (MOI = 100) for 
36 hours, equivalent to approximately a 12-fold overexpression vs endogenous SERCA. 
Although uniformity of ratiometric probes is not usually necessary, Cammito was 
expressed for 72 hours, which is described in Chapter 3, Figure 3.2.   
2.3 Mitochondrial calcium imaging 
ARVM expressing Cameleon probes were imaged using an Olympus IX70 
inverted epifluorescence microscope fitted with an Olympus DSU spinning disk  
confocal attachment and a Hamamatsu Orca ER cooled CCD camera  
[Olympus 60X 1.4 NA planapochromat oil immersion objective]. The light  
source was a Prior Lumen 220 Pro and dual emission images were acquired  
using a Prior Scientific high-speed filter changer. The filters and dichroic  
mirror where made by Chroma Technologies (ET 436/20X excitation, T455LP  
mirror, and ET 480/40M and ET 535/30M emission filters). Physiological  
temperature (37°C) and 5% CO2 was maintained using a InVivo Scientific  
incubation chamber. Images were acquired and analyzed using NIS-software.  
Ratios were calculated as FYFP/FCFP after background subtraction and thresholding. Cells 
were stimulated with either thapsigargin or DMSO control (1 µM, 30 minutes) or H2O2 






2.4 Quiescent Cytosolic Calcium Imaging 
 ARVM expressing WT SERCA, or SERCA C674S adenovirus were loaded with 
FURA-2 (AM) (1 µM, 30 minutes) and washed thoroughly before imaged on the 
Olympus microscope detailed in 2.3. Cells were treated with H2O2 (100 µM) or KH for 
20 minutes, then stimulated with caffeine (20 µM).  Ratios were calculated as F340/F380 
after background subtraction and thresholding.  
2.5 Mitochondrial Membrane Potential  
Mitochondrial membrane potential was measured using the voltage-sensitive 
fluorescent indicator, tetramethylrhodaminutese, methyl ester (TMRM; Thermo Fisher 
Scientific). Isolated ARVMs were loaded with TMRM (10 µM, 20 minutes) and washed 
thoroughly, followed by control or H2O2 (100 µM, 20 minutes) treatment prior to 
imaging with the Olympus IX70 inverted epifluorescence microscope described in 2.3.  
TMRM was imaged using the Olympus cube “U-MRFPHQ” (BP 535/555 excitation, BA 
570/625 emission, and DM565 mirror. Minimal fluorescence (Fmin) signal obtained by 
application of mitochondrial uncoupler, carbonyl cyanide m-chlorophenyl hydrazone 
(CCCP, 10 µM) was subtracted from baseline fluorescence (Fmax) then normalized to the 
daily control group.  
2.6 Western Blot Analysis 
 ARVM expressing WT SERCA, or SERCA C674S adenovirus plated on 35-mm 
laminin-coated culture dishes were treated with H2O2 (100 µM) for 15 minutes or 6 hours 
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for measuring levels of pyruvate dehydrogenase phosphorylation S293 (pPDH) or 
cytochrome C release respectively, with appropriate loading controls.  
To measure pPDH293, cells were washed with ice-cold PBS and lysed in 2% SDS 
lysis buffer (2% SDS, 5 mM EDTA). Lysates were sonicated at 20% duty cycle for 15 
seconds. Soluble lysates were separated by microcentrifugation and protein concentration 
was measured using BCA (Pierce), 60 µg protein aliquots were prepared for SDS-PAGE. 
pPDH293 was normalized to total cellular PDH. 
To measure cytochrome c release, cells were washed in ice-cold PBS then the 
cytosolic fraction was extracted with digitonin lysis buffer (75 mM KCl, 1mM NaH2PO4, 
8 mM Na2PO4, 250mM Sucrose, .05% digitonin) and placed on ice. The residual 
organelle fraction was lysed in 2% SDS buffer (2% SDS, 5 mM EDTA). Cell lysates for 
both experiments were sonicated at 20% duty cycle for 15 seconds. Soluble lysates were 
separated by microcentrifugation and protein concentration was measured using BCA 
(Pierce).  Aliquots representing 10 µg of protein from digitonin-permeabilized cytosolic 
were used to detect cytochrome c. 10 µg of protein from the organelle fraction was 
probed for GAPDH as a control for cell plating variability.   
All samples were boiled at 95°C for 5 minutes before being resolved by 10% 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The proteins 
were transferred to Immobilon-FL PVDF membranes (Millipore), blocked with Licor 
Odyssey blocking solution (Licor) for 1 hour at room temperature, and then incubated 
with the primary antibodies outlined in Table 1 at 4°C overnight. Protein was detected 
with IRDye® 680RD goat (polyclonal) anti-mouse IgG (H + L) or 800CW donkey 
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(polyclonal) anti-rabbit IgG (H + L) infrared (IR) conjugated secondary antibodies 
(Licor). 
Antibody Dilution Company 
pPDH293 1:1000 Novus Biologicals 
PDH1A 1:1000 Sigma-Aldrich 
Cytochrome C 1:1000 BD Pharmingen 
GAPDH 1:5000 Abcam 
Table 2.1. Antibodies used for Western Blot analysis. 
2.7 Apoptosis Assay  
Annexin V/ propidium iodide (PI) staining with the Annexin-V-FLUOS Staining kit was 
used according to manufacturer’s instructions. Briefly, ARVM infected with WT 
SERCA2b, or C674S SERCA2b adenovirus plated on 4 well (LabTek) glass bottom 
culture dishes (MatTek) precoated with laminin (10 μg/mL Invitrogen) were treated with 
H2O2 (100 µM, 24 hours) prior to incubation with annexin V and PI solutions provided by 
kit, for 20 minutes. Cells were washed thoroughly before imaging using a Nikon 
Deconvolution Wide-Field Epifluorescence System. The filters and dichroic mirrors 
where made by Chroma Technologies to acquire GFP FITC images for annexin V 
positive cells (ET 470/40X excitation, T4951LPXR mirror, and ET 525/50M emission), 
Texas Red for PI positive cells (ET 560/40X excitation, T585LPXR mirror, ET 630/75M 
emission) and bright-field images were acquired to count total number of cells. Images 
were acquired using NIS-software. ImageJ was used to analyze images, using the LOCI 
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Bioformats plugin (University of Wisconsin-Madison) was used to open the Nikon 
format images. 
 
2.8 Statistical analysis 
All data are reported as mean ± SEM. Significance testing (ANOVA or 
Student’s daily paired or unpaired t-test, column mean with correction) was performed 





















          Rationale 
Reactive oxygen species (ROS) play a central role in pathologic myocardial 
remodeling and the progression to heart failure.  One consequential target of ROS is the 
sarco-endoplasmic calcium ATPase (SERCA).  SERCA, the major protein responsible 
for calcium uptake into the SR, is regulated by multiple mechanisms108 including 
oxidative post-translational modification at cysteine 674 (C674): Reversible S-
glutathionylation at C674 activates SERCA, increasing calcium transients generating 
positive ionotropy, while irreversible S-sulfonylation inhibits enzyme activity, reducing 
calcium transients and contractility 35-37, 67.   Although these studies elucidate a role for 
ROS regulation of SERCA in modulating intracellular calcium, whether or not it affects 
mitochondrial calcium is unknown.   
Mitochondria require calcium for metabolic processes and cell survival 63,110. 
Recent appreciation of the close physical association between the SR and mitochondria 
increased interest in the mechanisms underlying cross-talk between these organelles. In 
mice with post-myocardial infarction ventricular remodeling, SR calcium leak via RyR 
causes mitochondrial dysfunction, increased H2O2 production, and ultimately myocardial 
failure 78. This study implicates SR-mitochondrial calcium regulation as a key 
determinant of myocardial function.  
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We have preliminary evidence that SERCA C674 oxidation may also mediate 
mitochondrial dysfunction. We found heterozygous, redox-insensitive mutant SERCA 
C674S knock in (SKI) mice 49 challenged by PO had significantly less myocardial 
dysfunction compared to WT mice.  Because mitochondrial dysfunction may precede 
myocardial dysfunction, this study indirectly suggests SERCA activity affects 
mitochondrial function 21.  Given the critical role of SERCA in regulating SR calcium 
content and the susceptibility of SERCA to oxidative regulation, we hypothesized that 
redox regulation of SERCA modulates mitochondrial calcium content.  Together, these 
observations suggest that SR calcium plays a critical role in mediating mitochondrial 
dysfunction, affecting myocardial homeostasis. 
 In order to test my hypothesis, I optimized a technique for measuring 
mitochondrial calcium using an adenovirus containing a highly sensitive mitochondrially-
targeted calcium Cameleon probe (CAMmito) generated by Dr. David Pimentel.  Using 
this tool, I measured the effect of SERCA oxidation on mitochondrial calcium and 
caffeine sensitive SR calcium content in WT or a redox-insensitive SERCA C674S 
expressing ARVM.   
Results 
Confirmation and protocol optimization of a mitochondrially-targeted calcium                            
sensitive Cameleon probe 
In order to measure mitochondrial calcium our laboratory generated an adenovirus 
containing a mitochondrially-targeted Cameleon probe 55,105.  Cameleon probes are 
calcium indicators containing two fluorescent proteins, cyan fluorescent protein (CFP) 
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and yellow fluorescent protein (YFP) variants, bound by a calcium sensitive calmodulin-
M13 domain. Binding to calcium alters the steric conformation, changing the CFP-YFP 
interaction.  The shift in conformation results in Föster resonance energy transfer (FRET) 
which can be qualitatively assessed by comparing the emission of the donor and acceptor 
proteins (figure 3.1) 105. Because the exact concentration of mitochondrial calcium at a 
given time in cardiac myocytes is unknown, we generated multiple adenoviral constructs 
containing Cameleon probes with varying binding affinities ranging from 15 nM to 140 
nM 63,111.  Briefly, we incubated ARVM with each adenovirus for 24 hours and imaged 
after 48 hours in culture.  We found the Cameleon with the most sensitive calcium 
affinity, Cameleon-Nano15 (Kd =15 nM) was the only construct that registered calcium 
dynamics in AVRM mitochondria.  Because the calcium binding affinity and fluorescent 
properties of CAMmito have not been determined in vitro 112 , it was important to 
independently calibrate CAMmito within the mitochondria of our cells.  Briefly, ARVM 
were incubated in a potassium phosphate HEPES buffer with BAPTA 5 nM with a pH = 
8 to mimic the pH of the mitochondrial matrix.  Cells were permeabilized with 
ionomycin (5 µM) and the minimum ratio was obtained prior to stepwise additions of 
CaCl2 until the maximum ratio was achieved 
106.  We found the EC50 of CAMmito to be 91 
nM, indicating a desensitization or a right shift in calcium affinity relative to in situ 




Figure 3.1. Structure and in vitro calibration of the mitochondrially-targeted yellow Cameleon-
Nano15. A. Cameleon calcium indicators contain two fluorescent proteins, a CFP and YFP variant, bound 
by a calmodulin-M13 domain.  In the presence of calcium, a conformational change alters the interactions 
between the two fluorescent proteins, generating a FRET signal 113 (schematic adapted from health-
abstracts.com). B. ARVM were incubated in a potassium phosphate HEPES buffer with BAPTA 5 nM and 
set at pH = 8 to mimic innate mitochondrial pH. ARVM were permeabilized using ionomycin (5 µM).  Rmin 
was determined before stepwise CaCl2 were added to generate the calibration curve until reaching Rmax. 
GraphPad Prism was used to determine the dose-response curve, with + 95% confidence interval 
boundaries, and calculate the EC50. (Calibration curve from Luptak et al. 106) 
 
Cameleon probes do not explicitly require expression optimization due to the 
ratiometric nature of the probe.  However, due to their inherently low signal to noise ratio 
compared to calcium sensitive dyes such as FURA-2, it was important to optimize 
expression. Low indicator expression reduces the signal to noise ratio, requiring more 
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light for excitation which introduces free radicals that can introduce imaging artifacts. 
Alternatively, if expression is too high Cameleon probes can buffer calcium which can be 
toxic to the cell and obstruct accurate measurements of free calcium 56.  Based on 
previous experiments, I compared CAMmito expression at 2 and 3 days (48 or 72 hours) 
after infection (figure 3.2).  CAMmito ARVM cultured for 2 days prior to experiments had 
variable GECI distribution and required substantially higher power and light exposure. 
Alternatively, CAMmito ARVM cultured for 3 days display uniform GECI distribution 
and with a high signal to noise ratio.  Additionally, I confirmed CAMmito localized to the 
mitochondria by visualizing co-localization with MitoTracker Red, a mitochondria 
specific fluorescent dye (figure 3.2).  
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Figure 3.2.  Fluorescent signal of CAMmito is optimal at 3 days of expression and localizes to the 
mitochondria.  Uniformity and localization of CAMmit was assessed using wide-field and confocal 
microscopy respectively. A. Adenoviral expression of CAMmito after 2 (left) or 3 (right) days in ARVM.  
Scale bar represents 25 µm. Imaged using an Olympus DSU microscope in WF setting. B. CAMmito was 
targeted to the mitochondria using 4x leader sequence of cytochrome C oxidase. Confirmation of 
mitochondrial localization was determined by overlay with MitoTracker Red.  Co-localization shown in 
third panel. Images were obtained using a Nikon Super-Resolution Microscope (structured illumination 
microscopy, demo instrument at Boston University Cellular Imaging Core).                     
 
SERCA activity modulates mitochondrial calcium 
Since SERCA is the primary calcium transporter and is located in close proximity to 
mitochondria, I hypothesized that SERCA inhibition would increase calcium 
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concentrated within the mitochondrial associated membrane (MAM), activating the 
calcium-sensitive mitochondrial calcium uniporter permeabilizing the IMM to 
mitochondrial calcium 114.  To test my hypothesis, I treated ARVM expressing CAMmito, 
with either the SERCA inhibitor thapsigargin (1 µM, 30 minutes) or control buffer 
(DMSO) and found that thapsigargin inhibition of SERCA increased mitochondrial 
calcium by 18% (figure 3.3). These findings indicate that SERCA activity modulates 
mitochondrial calcium.     
 
Figure 3.3. Mitochondrial calcium increases with SERCA inhibition.  Mitochondrial calcium 
concentration was measured using a GECI targeted to mitochondria (CAMmito). SERCA inhibition with 
thapsigargin (1 μM, 30 minutes) increased YFP/CFP fluorescence compared to DMSO control in ARVM 
expressing CAMmito (n = 8; ** = p < 0.01). 
 
RyR leak is the primary source of ROS mediated mitochondrial calcium 
As mentioned earlier, ROS regulation of SERCA has been identified in heart failure 
models in vivo 19,115.  Because mitochondrial calcium uptake appears to be thapsigargin-
sensitive, it is possible ROS regulation of SERCA affects mitochondrial calcium.  To test 
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my hypothesis, I exposed ARVM to H2O2 (100 µM, 10 minutes) and measured 
mitochondrial calcium using CAMmito. The concentration and duration of H2O2 treatment 
were previously found to diminished SR calcium and prolong SR calcium uptake 45, 
indicative of an oxidative inhibition of SERCA, therefore I hypothesized that 
mitochondrial calcium would increase, similar to our results in Figure 3.3. As anticipated, 
H2O2 caused mitochondrial calcium to gradually increase, achieving a mean increase of 
25% at 10 minutes (figure 3.4, A).  Since H2O2 can simultaneously increase SR calcium 
leak via RyR, we measured mitochondrial calcium in the presence of tetracaine (100 µM, 
20 minutes) an RyR inhibitor 78. We found that RyR inhibition decreased the H2O2-
stimulated rise in mitochondrial calcium concentration by 85%, indicating that a major 
portion of the increase is mediated by calcium released from the SR (figure 3.4, B).  
Taken together, these data indicate that RyR leak, as opposed to oxidative inhibition of 











Figure 3.4. H2O2 - stimulated mitochondrial calcium uptake is RyR dependent. Adult rat 
ventricular myocytes (ARVM) were exposed to H2O2 (100 µM, final concentration) or control 
media with or without pretreatment with the ryanodine receptor inhibitor tetracaine (Tet; 100 µM; 
20 minutes). Panel A. Representative images at baseline and 10 minutes after exposure to H2O2 
with or without pretreatment with tetracaine. H2O2 was added at time = 0; green represents the 
lowest mitochondrial calcium concentration and red the highest. Scale bar represents 25 µm. 
Panel B. Representative experiment depicting mitochondrial calcium concentration over 10 
minutes following exposure to H2O2 with (open circles) or without (solid triangles) pretreatment 
with tetracaine. Solid squares represent control media. Each time point is the mean of 8-12 cells 
per condition. Mitochondrial calcium concentration is expressed as the ratio of emission 
fluorescence (FYFP / FCFP) normalized to the baseline ratio at time = 0 (R0). Panel C. Mean 
changes in mitochondrial calcium concentration measured 10 minutes after the addition of H2O2 
(n= 5 - 11; *** = p < 0.001 vs. control; ### = p < 0.001 vs. H2O2).  
 
To assess the role of SR calcium in mediating the H2O2-stimulated increase in 
mitochondrial calcium, we used Fura-2 to measure the change in cytosolic calcium 
concentration in response to a rapid application of caffeine (20 mM). Pretreatment with 
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H2O2 (100 µM; 20 minutes) caused approximately a 50% decrease in caffeine-sensitive 
SR calcium content (figure 3.5). Tetracaine treatment prior to H2O2 almost completely 
prevented the H2O2-mediated decrease in caffeine-sensitive SR calcium. These findings 
indicate that the H2O2-stimulated increase in mitochondrial calcium concentration is 
mediated, in large part, by the release of SR calcium via RyR, as opposed to oxidative 
inhibition of SERCA.  
  
 
Figure 3.5. H2O2 mediated depletion of caffeine-sensitive SR calcium release is prevented by 
RyR inhibition.  ARVM loaded with the cytosolic calcium indicator FURA-2 (AM) were 
incubated with control media (Control) or H2O2 (100 µM; 20 minutes) with or without tetracaine 
(Tet) pretreatment (100 µM; 20 minutes) prior to the addition of caffeine (20 mM) to release SR 
calcium. Panel A. Representative trace showing the caffeine-stimulated increase in cytosolic 
calcium (F340/F380)/Ro), which is reflective of SR calcium content. Cells were depolarized at t = 0; 
solid line = control media; dashed line = H2O2; dotted line = Tet + H2O2. Each trace is the mean of 
8-12 cells. Panel B. Mean SR content following incubation with H2O2 with or without tetracaine 








Redox regulation of SERCA C674 modulates mitochondrial calcium  
and SR content 
SERCA C674 oxidation has been implicated in ROS mediated pathological 
remodeling in vivo 19,115. To assess the role of SERCA C674 oxidation in mediating the 
H2O2-stimulated increase in mitochondrial calcium, WT SERCA or the redox-insensitive 
SERCA C674S mutant were expressed with CAMmito in ARVM followed by an oxidant 
challenge.  In cells expressing WT SERCA, exposure to H2O2 increased mitochondrial 
calcium concentration by 20%.  In cells expressing the C674S mutant, basal 
mitochondrial calcium concentration was decreased by 6% (vs. WT SERCA) and the 
H2O2-stimulated rise in mitochondrial calcium was decreased by 40% as compared to 
cells expressing WT SERCA (figure 3.6).
 
Figure 3.6. SERCA C674 oxidation modulates basal and H2O2-stimulated mitochondrial 
calcium. ARVM expressing WT SERCA or the redox-insensitive SERCA C674S mutant were 
stimulated with H2O2 (100 µM, 10 minutes) as per Figure 3.5. Mean mitochondrial calcium 
concentration expressed as the ratio of YFP/CFP fluorescence (n = 10-11; * = p < 0.05, *** p = 




The observed decreases in basal and H2O2-stimulated mitochondrial calcium in 
C674S-expressing ARVM raised the possibility that these cells have less basal SR 
calcium. Therefore, SR calcium content was assessed by measurement of caffeine-
stimulated calcium release (figure 3.7). In cells expressing WT SERCA, H2O2 caused a 
49% depletion in caffeine-sensitive SR calcium release (figure 3.7). In cells expressing 
the C674S mutant, basal SR calcium content was decreased by 31% (vs. WT cells). 
However, residual SR calcium content after exposure to H2O2 was similar to WT cells 
after exposure to H2O2. These findings indicate that for cells expressing the SERCA 
C674S mutant: a) basal SR calcium stores are depressed; b) the magnitude of H2O2-
stimulated SR calcium release is diminished and; c) the H2O2-stimulated rise in 
mitochondrial calcium is attenuated. 
 
Figure 3.7. SERCA C674 oxidation modulates basal and H2O2-stimulated caffeine-
stimulated SR calcium release. ARVM expressing WT SERCA or the redox-insensitive 
SERCA C674S mutant were stimulated with H2O2 (100 µM, 20 minutes) as per Figure 3.6.  A. 
Caffeine-stimulated SR calcium release in WT and C674S mutant-expressing ARVM with or 
without incubation with H2O2 (n = 5 - 6; * = p < 0.05, ** = p < 0.01 vs. WT; O = p < 0.05 vs 










In this chapter we provide novel information on the role of SERCA in cross-
organelle, SR-mitochondrial calcium signaling.  I optimized a protocol for measuring 
mitochondrial calcium using a highly sensitive CAMmito probe. Using this tool in 
conjunction with caffeine-stimulated SR release experiments, we made three novel 
observations regarding the role of SERCA oxidation in the regulation of SR and 
mitochondrial calcium in cardiac myocytes. First, SERCA activity modulates 
mitochondrial calcium.  Second, under basal conditions, oxidation of SERCA C674 
regulates both SR calcium content and mitochondrial calcium concentration. Third, 
SERCA C674 oxidation modulates mitochondrial calcium in response to H2O2 by 
regulating SR content. 
Measuring mitochondrial calcium in cardiac myocytes requires the use 
of a high affinity calcium indicator 
In the cardiac myocyte, intracellular calcium fluctuates dramatically during the 
contractile cycle.  Calcium is also responsible for regulating processes such as 
metabolism and cell death. Due its ubiquitous nature, calcium is tightly buffered or 
discretely stored to mitigate off target effects.  Our understanding of calcium signaling 
within the myocyte has evolved in parallel with the tools used to measure it.  Here, I 
measured calcium within the matrix of the mitochondria by expressing a highly sensitive 
GECI, specifically a Cameleon probe, targeted to the mitochondria using an adenovirus. 
There are multiple generations of GECI’s, increasing in sensitivity and fluorescent 
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emission efficiency.  Mitochondrial calcium in resting cardiac myocytes has been 
described by different groups to range between 50-200 nM 116,117, yet to our surprise, only 
the most sensitive Cameleon construct (Kd=15 nM) indicated dynamic calcium changes.  
However, when we calibrated CAMmito in vitro, we found the Kd to be closer to 90 nM, a 
value consistent with prior calculations of mitochondrial calcium concentration. The 
discrepancy is likely due to variation in calibration techniques (in situ vs. in vitro), cell-
type specific behavior of the probe, and lack of standardized methods 56,118,119.  It is also 
important to note that quantitative measurements using Cameleon probes are limited due 
to substantial overlap between donor and acceptor fluorescence, therefore these values 
should not be taken as exact measurements. On the other hand, Cameleons are excellent 
tools for measuring calcium flux within cardiac myocytes because artifacts, including 
transient myocyte contractions, are limited due to the ratiometric nature of the probe.  
I further optimized our protocol for measuring mitochondrial calcium with 
CAMmito by performing experiments after 3 days in culture, as opposed to 2, in order to 
increase indicator expression. Increasing the duration of CAMmito expression did not 
disrupt myocyte structure or alter localization as shown in figure 3.2.  Additionally, it is 
unlikely I affected free calcium concentrations because GECI’s have limited calcium 
buffering capacity compared to small molecule dyes 120. By culturing ARVM for 3 days 
prior to experiments I reduced the amount of light needed for excitation, while also 
increasing uniformity of expression throughout the myocyte (Figure 3.2) 121. New 
generations of calcium indicators are able to generate a strong signal with even less 
excitation and reduced autofluorescence 122.  Tools to measure calcium will likely 
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continue to evolve, providing researchers with new insights into discrete calcium 
signaling pathways.     
 
Redox regulation of SERCA C674 modulates basal and H2O2-stimulated 
mitochondrial calcium by determining SR calcium content 
While prior studies have evaluated the role of SERCA activity in modulating 
cytosolic calcium and contractility, this is the first study to identify SERCA modulation 
of mitochondrial calcium in cardiac myocytes.  I found SERCA inhibition with 
thapsigargin increased mitochondrial calcium.  While SERCA inhibition has been 
reported previously to increase mitochondrial calcium in mouse thymocytes and a 
mastocytoma cell line, this is the first study to our knowledge to demonstrate this effect 
in cardiac myocytes 123. Because redox regulation of SERCA can be inhibitory, I tested 
the role of oxidative inhibition of SERCA on mitochondrial calcium 45,109.  Although I 
used a stimulus previously shown to inhibit SERCA, we observed that exposure to H2O2 
caused an increase in mitochondrial calcium that was markedly attenuated by the RyR 
inhibitor tetracaine, indicating that the majority of the calcium responsible for the 
increase in mitochondrial calcium was released from the SR via RyR. These results 
suggest that this stimulus activated, as opposed to inhibited, SERCA activity.  Prior 
studies have demonstrated that tetracaine-sensitive SR calcium release increases 
mitochondrial calcium. The increase in mitochondrial calcium presumably occurs due to 
a local increase in calcium concentration near the mitochondrial calcium uniporter 67. For 
example, in adult feline myocytes overexpression of the L-type channel β2a subunit that 
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causes SR calcium overload is associated with increased mitochondrial calcium and 
apoptosis 124. Similarly, mice expressing a leaky mutant RyR developed mitochondrial 
calcium overload and activation of the mitochondrial apoptosis pathway 78.   It is likely 
that H2O2 activation of SERCA led to mitochondrial calcium uptake by SR content, 
thereby increasing the amount of calcium that can be released by the RyR.  Thus, 
targeting RyR leak and/or SERCA oxidation are potential therapeutic targets for 
preventing mitochondrial calcium overload sufficient to stimulate cell injury and death.   
It is important to consider the possibility of off target effects of H2O2.  For 
example, the MCU can be directly activate by H2O2. Specifically, oxidation of MCU C97 
causes persistent activation and calcium influx 67.  That being said, in our study 
mitochondrial calcium uptake was tetracaine-sensitive, indicating the SR was the primary 
source of calcium, as opposed to direct activation of the MCU.  Alternatively, 
characterization of the MCU KO mouse suggested there are MCU independent 
mitochondrial calcium influx pathways.  This is supported by the surprising retention of 
basal mitochondria function, including ATP production in MCU KO mice 68. The Sheu 
group has hypothesized and provided controversial evidence for mitochondrial type-1 
RyR (mRyR) on the mitochondrial membrane 125.  If true, it is possible tetracaine blocked 
this pathway, contributing to the tetracaine sensitive reduction in H2O2-stimulated 
mitochondrial calcium uptake.  However, the potential off target effects of tetracaine 
would not detract from our overall conclusion, that SERCA C674 oxidation regulates 
mitochondrial calcium in the presence or absence of H2O2. 
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Oxidation of SERCA C674 can either activate or inhibit enzyme activity 45,49. The 
finding that both SR calcium content and mitochondrial calcium concentration were 
decreased in ARVM expressing redox-insensitive SERCA C674S suggests that under 
basal conditions, the endogenous level of oxidants sufficiently activates SERCA to 
maintain the normal SR calcium level. These data are consistent with preliminary studies 
performed on isolated myocytes from SKI mice (refer to Chapter 1) where we found that 
C674S sarcomere shortening and the amplitude of the depolarization-stimulated calcium 
transient were depressed, indicating that under physiologic conditions oxidation of 
SERCA C674 contributes to basal SR calcium content. These data demonstrate ROS 
regulation of basal SR calcium stores, and thus provide novel information on how the 
redox status of a cell regulates intra-organelle calcium and how an increase in oxidative 
stress causes aberrant calcium signaling in part due to SERCA oxidation. 
Conclusion 
Regulating mitochondrial calcium has become a potential therapeutic target in the 
cardiovascular field due to the overwhelming evidence that mitochondrial calcium 
overload contributes to the pathophysiology in models of heart failure in vitro and in 
vivo. In this chapter we identified a novel calcium signaling pathway between the SR and 
mitochondria, whereby SERCA activity and specifically, oxidation of SERCA C674, 
modulates basal and H2O2–stimulated mitochondrial calcium by regulating SR calcium 
load. These data provide rationale for targeting SERCA C674 oxidation in order to 










    Rationale 
  In Chapter 3 we identified SERCA C674 oxidation modulates mitochondrial 
calcium. This observation raised the possibility that SERCA C674 oxidation alters 
mitochondrial function and cell survival.  Under pathological conditions, mitochondrial 
dysfunction drives excess ROS generation associated with mitochondrial calcium 
overload. Mitochondrial calcium is an important regulator of mitochondrial ATP 
production but excess mitochondrial calcium is a well-documented stimulus for cell death 
in cardiac myocytes.  Multiple studies have identified ROS dependent activation of the 
intrinsic apoptosis pathway in vitro and in vivo, however mechanisms responsible for this 
untoward effect are not fully understood 8,19.   
We have preliminary evidence suggesting that SERCA C674 oxidation mediates 
apoptosis in cardiac myocytes.  Mice expressing redox-insensitive SERCA C674S (SKI 
mice) subjected to chronic pressure overload, a model of cardiac oxidative stress, were 
resistant to cardiac myocyte apoptosis implicating a potential role for SERCA C674 in 
regulating cell survival. To test the hypothesis SERCA C674 oxidation mediates 
apoptosis in vitro, ARVM expressing WT SERCA or SERCA C674S were treated with 
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H2O2 at a concentration and duration known to induce apoptosis and measured indictors 





SERCA C674 oxidation regulates calcium dependent activation of pyruvate 
dehydrogenase 
Mitochondrial calcium is essential for activation of key metabolic enzyme processes, 
but too much or too little calcium can have detrimental effects on mitochondrial function.  
Pyruvate dehydrogenase (PDH) is an indispensable, rate-limiting enzyme whose activity 
is indirectly dependent on mitochondrial calcium.  Calcium entry into the mitochondria 
activates the calcium sensitive phosphatase required for dephosphorylation of pPDH293, 
thereby activating PDH (figure 4.1). Accordingly, PDH phosphorylation or activity has 
been used as a surrogate measurement of mitochondrial calcium, and to understand the 
relationship between calcium signaling and metabolism 126,127. Activated PDH catalyzes 
pyruvate into Acetyl CoA + CO2 which can then enter the Krebs cycle. Because H2O2 
stimulated mitochondrial calcium uptake was significantly greater in WT vs C674S 
expressing ARVM, I hypothesized that PDH would be more active (i.e., there would be 
more dephosphorylated PDH293) in WT compared to C674S cells.  To test my hypothesis, 
I measured phosphorylation of PDHS293 (by Western blot) compared to total PDH as an 
indicator of PDH activity, before and after an oxidant challenge.  In WT cells, I found 
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that H2O2 stimulation decreased pPDH
293 (suggesting activation of PDH had occurred) by 
64%.  On the other hand, H2O2-stimulation decreased pPDH
293 in SERCA C674S-
expressing cells by about 50% (figure 4.2).  The difference in H2O2-stimulated activation 
of PDH did not reach statistical significance, likely due to a low sample size and large 
cell preparation variability.  Nevertheless, this trend supports our earlier finding that 
H2O2–stimulated mitochondrial calcium entry is reduced in C674S cells compared to 
WT. These data, if confirmed with additional experiments, would suggest that redox 
regulation of SERCA C674 affects mitochondrial metabolism. 
 
Figure 4.1. Calcium entry into the mitochondrial matrix indirectly regulates pyruvate dehydrogenase 
activity. Calcium entry into the mitochondrial matrix stimulates substrate utilization by binding to and 
activating phosphor-PD phosphatase, which activates PDH via dephosphorylation of pPDH293. Image from 




Figure 4.2. H2O2-stimulated PDH activation is reduced in ARVM expressing redox-insensitive 
SERCA C674S. PDH activity was assessed in ARVM expressing WT or SERCA C674S by measuring 
PDH293 phosphorylation using Western Blot after control or H2O2 (100 µM, 15 minutes) treatment. Panel 
A. Representative Western Blot. Panel B. Mean levels of basal and H2O2-stimulated pPDH293 normalized 
to total PDH (n = 4; *** = p < 0.0001 vs. WT- H2O2; 
oo
 < 0.001 vs. C674S- H2O2).  Panel C. Mean percent 
change of pPDH in response to H2O2 (n = 4; p = 1.2). 
 
H2O2 mediated activation of the intrinsic apoptosis pathway is dependent on  
SERCA C674 oxidation 
Next, I investigated the role of SERCA C674 oxidation in regulating apoptosis in 
vitro.  We have preliminary data indicating SKI mice (refer to Chapter 1.2) are protected 
from apoptosis post-chronic pressure overload. Therefore, we hypothesized that SERCA 
C674 oxidation modulates apoptosis by means of affecting mitochondrial calcium.  To 
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test my hypothesis, I first measured cytosolic vs membrane bound cytochrome c. The 
release of cytochrome c from the mitochondria is a well-documented marker of early-
stage apoptosis 10.  ARVM expressing WT or C674S were challenged with H2O2 (100 
µM) or control for 6 hours.  H2O2 caused a 5.5-fold increase in cytosolic cytochrome c 
(figure 4.3) in WT cells, which was attenuated by 77% in C674S cells.   
 
 
Figure 4.3. H2O2-stimulated cytochrome c release is decreased in ARVM expressing the SERCA 
C674S mutant. Representative Western Blot of released cytochrome c measured 6 hours after the addition 
of H2O2 (100 µM). Mean levels of basal and H2O2-stimulated cytochrome c release as per Panel A, 
normalized to total protein assessed by GAPDH expression in the cellular organelle fraction, then 
normalized to WT (control), (n = 4; * = p < 0.05 vs. WT; # = 0.05 vs. WT - H2O2). 
 
 Next, we probed for markers of late stage apoptosis using an annexin V/ propidium 
iodide (PI) assay.  Annexin V binds to phosphatidylserine which is flipped to the 
extracellular surface of the plasma membrane during apoptosis.  It was previously shown 
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that the annexin V staining, in the absence of an increase in PI staining, is a marker of 
ROS-stimulated apoptosis in ARVM 8. For this experiment I exposed WT or SERCA 
C674S cells to H2O2 (100 µM, 24 hours), then measured annexin V positive cells, 
represented by FITC fluorescence.     
In WT cells, H2O2 treatment caused a 190% increase in annexin V expression. In 
C674S-expressing cells, H2O2 treatment caused a 128% increase in annexin V 
expression, a 62% reduction vs WT (figure 4.4.). There were no measurable differences 
in PI staining between WT and C674S expressing cells at baseline. H2O2 stimulation did 
not markedly increase PI staining indicating our treatment caused apoptosis rather than 
necrosis.  Together, these data indicate that SERCA C674 oxidation mediates apoptosis 
by modulating mitochondrial calcium.  
 
Figure 4.4. H2O2-stimulated apoptosis is reduced in ARVM expressing the redox-insensitive 
SERCA C674S.  Basal and H2O2-stimulated (100 µM, 24 hours) expression of annexin V and PI 
in ARVM expressing WT or C674S SERCA (Annexin positive; n = 4 - 5; ** = p < 0.01 vs. WT; # 






H2O2 –mediated alterations in cytosolic ATP/ADP and mitochondrial membrane 
potential are independent of SERCA C674 oxidation 
ATP production in the mitochondria relies on calcium dependent activation of key 
mitochondrial enzymes. Because SERCA C674 modulates mitochondrial calcium, we 
hypothesized SERCA C674 oxidation would also affect ATP production and therefore 
the ATP/ADP ratio.  The ATP/ADP ratio provides an indirect measurement of 
mitochondrial function and cellular metabolism 129. To measure the cytosolic ATP/ADP 
ratio, I used Perceval-HR, a cytosolically-targeted fluorescent ratiometric probe. 
Experiments were performed after 3 days of adenovirus culture.  Briefly, we acquired 
baseline images at time 0 followed by a bolus of ROS (100 µMF, 10 minutes), with 
subsequent images taken at 1 minute intervals for 15 minutes.   
We found no significant difference in cytosolic ATP/ADP before or after ROS 
stimulation.  H2O2 treatment caused a decrease in ATP/ADP by 35% and 49% in WT and 
C674S cells respectively (figure 4.5).  The ATP/ADP ratio is affected by more than 







Figure 4.5. Redox-regulation of SERCA C674 does not affect the cytosolic ATP/ADP ratio 
before or after H2O2 –treatment. Cytosolic ATP/ADP ratio was measured using the fluorescent 
ratiometric indicator Perceval-HR, after bolus of H2O2 treatment (final concentration; 100 µM). 
Images were taken every 1 minute for 15 minutes.  Panel A. Mean levels of basal and H2O2-
stimulated ATP/ADP as indicated by the fluorescence of GFP/390. (n=4; *** p = 0.001 vs WT; 
OOO p < 0.001 vs C674S; p = 0.2 WT- H2O2 vs C674S- H2O2) Panel B. Mean percent change in 
fluorescence in response to H2O2 (p = 0.1).  
 
Another important consequence of ROS mediated calcium overload is depolarization 
of the mitochondrial membrane 130,131.  Mitochondria tightly regulate ion transport into 
the matrix in order to maintain a potential between -150mV and -180mV.  This 
electrochemical gradient is necessary for generating the proton motor force responsible 
for ATP synthase activity 132.  In a pathological model, calcium movement into the 
mitochondrial matrix can depolarize the membrane, reducing the gradient required for 
oxidative phosphorylation.  Depolarization of the mitochondrial membrane is one 
indicator of mitochondrial dysfunction and precedes apoptosis 133.  Oxidative stress has 
been shown to decrease the membrane potential, in part due to mitochondrial calcium 
uptake, however whether SERCA oxidation affects this pathway is unknown 134.  I 
proposed that the H2O2 mediated mitochondrial uptake would depolarize the 
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mitochondrial membrane in WT cells but not C674S-expressing cells.  To test my 
hypothesis, I loaded WT and C674S expressing ARVM with tetramethylrhodaminutese 
methyl ester perchlorate (TMRM; 10 µM, 20 minutes) after a control or oxidant 
challenge (H2O2; 100 µM 20 minutes).   After establishing baseline fluorescence, I 
applied a bolus of CCCP (10 µM) and imaged TMRM fluorescence at 1 second intervals 
for 75 seconds.  CCCP treatment is used to obtain the minimum florescence value by 
completely depolarizing the membrane.  I found no difference in membrane potential at 
rest or with H2O2 –treatment.  Mitochondrial membrane potential trended lower in 
C674S-expressing cells compared to WT-expressing cells.   These contradict our findings 
in Chapter 3, whereby C674S-expressing cells had significantly less mitochondrial 
calcium, that would be expected to further polarize the membrane potential.  H2O2 
treatment caused a significant decrease in TMRM fluorescence in both cell groups (figure 
4.6). Taken together, these observations suggest that modulation of mitochondrial 
calcium by SERCA C674 does not affect mitochondrial membrane potential and suggests 







Figure 4.6. Redox-regulation of SERCA C674 does not affect mitochondrial membrane 
potential before or after acute H2O2 -treatment. WT and C674S expressing cells loaded with 
TMRM were treated with media control or H2O2 (100 µM, 20 minutes).  Baseline fluorescence 
was acquired before CCCP (10 µM) treatment and images were acquired at 1 second intervals for 
75 seconds.  CCCP depletion of TMRM fluorescence in media (control) WT cells was set to 
100%.  Panel A. Baseline membrane potential trended lower in C674S compared to WT (p = 
.18).  ROS treatment significantly decreased CCCP sensitive TMRM fluorescence in WT cells (* 
p = .05 vs WT- H2O2) yet only trended lower in C674S cells (p = .1 vs C674S - H2O2). Panel B. 
Mean percent change in TMRM fluorescence in response to H2O2. 
 
Discussion 
 In the previous chapter we identified SERCA C674 oxidation mediates basal and 
H2O2–stimulated SR-mitochondrial calcium signaling. This finding raised the possibility 
that SERCA C674 oxidation modulates calcium dependent mitochondrial processes 
including matrix enzyme activation and apoptosis. We found expression of redox-
insensitive SERCA C674S inhibited PDH activity and apoptosis yet did not significantly 
affect cytosolic ATP/ADP.  These observations can be attributed to calcium regulation by 
SERCA C674 described in Chapter 3.  These observations demonstrate that SERCA 
C674 oxidation dependent SR-mitochondrial calcium signaling plays a significant role in 




Redox-regulation of SERCA C674 stimulates calcium dependent  
matrix enzyme PDH 
Aberrant mitochondrial calcium signaling contributes to mitochondrial dysfunction 
in models of heart failure in vivo and in vitro, yet the mechanism is not fully understood 
78. Because we found SERCA C674 oxidation led to increased mitochondrial calcium 
after an oxidant challenge, which was significantly reduced in cells expressing redox-
insensitive SERCA C674S, we hypothesized SERCA C674 oxidation modulates 
mitochondrial metabolic pathways.  To test our hypothesis, we challenged ARVM 
expressing WT or SERCA C674S with an acute H2O2 (100 µM, 15 minutes) treatment 
and measured PDH activity.  PDH links glycolysis to the Krebs cycle by catalyzing 
pyruvate into Acetyl CoA and CO2. PDH depends on activation by calcium dependent 
dephosphorylation (figure 4.1). In addition, this experiment has previously been used as a 
surrogate measurement of mitochondrial calcium uptake 114,135.   
We found H2O2 stimulation increased PDH activity in WT and to a lesser extend in 
C674S expressing cells.  Although we were unable to measure a significant difference 
between ROS stimulated PDH activity, likely due to a low sample size, this trend 
supports our previous finding where H2O2-stimulation increased tetracaine sensitive 
mitochondrial calcium uptake, which was inhibited in SERCA C674S expressing cells.  
SR calcium leak has been previously shown to affect PDH activity.  Mice lacking 50% of 
cardiac RyR exhibited hyperphosphorylation and inhibition of PDH activity 126.     
Interestingly, the authors of the study suggest the decrease in RyR mediated SR calcium 
transfer to the mitochondria leads to a shift in energy production from oxidation to 
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glycolysis 126.  This metabolic switch is thought to be responsible for reducing flexibility 
in energy production and is a key characteristic of HF. Taken together, SR- mitochondrial 
calcium crosstalk mediated by SERCA C674 likely influences mitochondrial function 
and could potentially affect the metabolic switch that occurs during HF. 
Redox-insensitive SERCA C674S prevents activation of 
the intrinsic apoptosis pathway 
 Mitochondrial dysfunction in heart failure is associated with activation of the 
mitochondrially-driven cell death pathway, apoptosis.   Mitochondrial calcium overload 
is one characteristic of mitochondrial dysfunction that directly initiates apoptosis.  In the 
previous chapter, we found SERCA C674 oxidation modulated mitochondrial calcium. 
This finding led us to investigate the potential role of SERCA C674 oxidation in 
activating apoptosis. We challenged WT and SERCA C674S expressing cells with a 
known apoptotic ROS stimuli and found SERCA C674S cells had markedly less 
apoptosis 8.  H2O2-stimulated apoptosis, was reflected by cytochrome c release and 
annexin V expression, which was prevented in ARVM expressing the C674S mutant.   
These data confirm experiments performed in vivo, where chronic pressure overload 
induced apoptosis was prevented in SKI mice.  In Chapter 3, we determined the source 
for mitochondrial calcium uptake was SR calcium leak via the RyR receptors.   We 
propose SERCA C674 oxidation regulates apoptosis by determining the amount of 
calcium available for mitochondrial uptake in response to oxidative stress.   Multiple 
groups have identified pathological SR calcium leak as the source for mitochondrial 
calcium overload and apoptosis  78,124. For example, mice overexpressing the β2a subunit 
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of the L-type calcium channel demonstrated increased mitochondria-mediated apoptosis 
of cardiac myocytes which was both dependent on SR calcium and prevented by 
blockade of the RyR 124. Similarly, preventing mitochondrial calcium overload caused by 
ischemia reperfusion has prevented activation of the apoptosis pathway in isolated rat 
hearts 136.  
Although there is substantial evidence for mitochondrial calcium overload 
induces apoptosis in H2O2 mediated models of heart failure, some investigators have 
shown that a reduction in mitochondrial calcium drives apoptosis in heart failure models.  
The proposed mechanism being that high sodium content within the cytosol causes the 
electrochemically gated Na+/Ca2+ exchanger to work in reverse mode, removing calcium 
from the mitochondria 37,137.  For example, one study showed cell death was prevented by 
a non-specific NCE and calcium channel blocker, used to increase mitochondrial calcium 
138.  Lastly, some groups have reduced apoptosis in models of heart failure by inhibiting 
molecular components of the mPTP such as ANT and CypD in cardiac myocytes 79,139.  
On the other hand, acute stress stimuli can cause transient activation of the mPTP which 
can be protective by temporarily depolarizing the membrane, releasing calcium from the 
mitochondrial matrix to restore homeostasis and inhibiting apoptosis 140–142.  
Pathological ROS signaling can cause ROS induced ROS generation, a 
pathological feedback system which can sensitize the mPTP to calcium, increasing the 
chances of apoptosis 70,143,144.  It is possible the reduction in H2O2 mediated mitochondrial 
calcium uptake and PDH activation in ARVM expressing redox-insensitive SERCA is a 
protective measure to reduce pathological ROS generation which can promote apoptosis.  
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This hypothesis is supported by preliminary in vivo data where the myocardium of SKI 
mice displayed less 4-hydroxynonenal (HNE) staining, a histological measurement of 
lipid peroxidation indicating less oxidative stress after chronic PO compared to WT mice. 
Oxidative stress, calcium dysregulation and ATP availability have all been found to 
influence the apoptosis pathway cardiac myocytes.  There is speculation that two of these 
factors must be present in order to induce apoptosis, acknowledging the potential 
complexity of inducing apoptosis in cardiac myocytes 145.   Our data identifies SERCA 
C674 oxidation as novel mediator that can potentially be targeted to reduce oxidative 
stress induced apoptosis in cardiac myocytes. 
H2O2- mediated activation of calcium sensitive mitochondrial processes is likely 
independent of SERCA C674 oxidation 
To understand how SERCA C674 oxidation influences metabolism at a cellular 
level, we measured the cytosolic ATP/ADP ratio using Perceval-HR, a fluorescent 
indicator expressed in ARVM via adenoviral infection.  The ATP/ADP ratio is an 
indicator of the metabolic state of a cell that is influenced heavily by mitochondrial 
function129.  Cardiac myocytes sustain a high ATP/ADP ratio to facilitate oxidative 
phosphorylation and inhibit glycolysis 146.  I found that WT and C674S expressing cells 
had nearly identical basal ATP/ADP ratios. This finding is supported by preliminary 
experiments demonstrating almost identical contractile performance despite alterations in 
calcium signaling.  These data suggest the basal difference in mitochondrial calcium 
within WT vs. C674S cells does not affect basal cytosolic ATP/ADP ratio (figure 4.3). 
Similarly, there was no difference in ATP/ADP ratio after H2O2 treatment. This was 
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contrary to my hypothesis that WT expressing cells would have a greater decline in 
ATP/ADP ratio than the C674S expressing cells.  I expected to see a difference between 
WT and C674S expressing cells for two reasons; First, mitochondrial ATP production is 
calcium sensitive and SERCA C674S expressing cells had reduced H2O2-stimulated 
mitochondria calcium uptake. Second, H2O2-mediated SERCA C674 oxidation has been 
shown to increase enzyme activity and ATP utilization, which is prevented in SERCA 
C674S expressing cells 45.   It is possible we did not detect differences in cytosolic 
ATP/ADP because the creatine-kinase pathway could have been activated, diminishing 
the role of mitochondrial calcium for energy production.  Within the cytoplasm, the 
creatine kinase pathway quickly generates ATP by coupling dephosphorylation of PCr 
with ADP by creatine phosphokinase 147.  To assess the role of SERCA C674 oxidation in 
mediating mitochondrial function one should focus on directly measuring mitochondrial 
ATP production as opposed to cytosolic ATP/ADP. 
 We also found the mitochondrial membrane potential at rest and after ROS 
treatment to be independent of SERCA C674 oxidation.  The mitochondrial membrane 
potential generates an electrochemical gradient required for oxidative phosphorylation.  
Ions including calcium, chloride, sodium and potassium are tightly regulated to maintain 
a membrane potential close to -180mV 148.  Under pathological conditions, the movement 
of calcium ions into the mitochondrial matrix without concurrent removal of positive ions 
will likely depolarize the mitochondrial membrane. In this study we found SERCA C674 
did not affect resting mitochondrial membrane potential. The difference in basal 
mitochondrial calcium identified in Chapter 3 did not affect basal mitochondrial 
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membrane potential.  Our finding could be due to compensatory mechanisms such as 
altered expression and, or activity of mitochondrial calcium exporters including the 
sodium calcium exchanger (NCLX) and the hydrogen calcium exchanger (LETM1).  
H2O2-stimulation depolarized the mitochondrial membrane potential significantly 
in WT and mildly, although not significantly in C674S cells. However, the ROS mediated 
percent change in depolarization was independent of SERCA C674.  These results trend 
against our findings in Chapter 3, where H2O2 treatment caused significant mitochondrial 
calcium uptake.  It is possible the mPTP underwent a low-conductance opening in order 
to restore the membrane potential 149.  Alternatively, it is also possible I did not assess the 
mitochondrial membrane potential at the appropriate time point. Because depolarization 
of the mitochondria precedes cytochrome C (6 hours) release but occurs after 
mitochondrial calcium uptake (20 minutes), I should have performed a time course and 
selected the duration that nearly completely depolarizes the membrane potential, 
preceding apoptosis.    
Conclusion 
In conclusion, our study suggests SERCA C674 mediates ROS-stimulated 
apoptosis.  We inhibited apoptosis by expressing a redox-insensitive SERCA C674S 
mutant, likely through a calcium-dependent mechanism.  However, calcium-dependent 
mitochondrial processes appear to function independently of SERCA C674 oxidation 
after acute ROS treatment.   These observations demonstrate a novel role for SERCA in 





In this thesis we describe a novel pathway whereby SERCA C674 oxidation 
modulates mitochondrial calcium, indirectly regulating apoptosis.  The role of 
mitochondrial calcium in activating apoptosis has previously been described, however the 
exact molecular mechanisms for this process are largely unknown.   
 Calcium dependent, mitochondrial dysfunction commonly precedes apoptosis.  
Metabolic coupling via calcium dependent metabolic enzymes stimulates ATP 
production in response to calcium entry into the mitochondria, yet an influx in calcium in 
conjunction with a reduction in ATP production can activate the apoptosis pathway.  We 
discovered the regulation of SR calcium content by oxidation of SERCA C674 modulates 
mitochondrial calcium and apoptosis in response to an oxidant challenge; However, we 
did not assess whether the calcium phenotype affected ATP production in this thesis.  
Potential experiments to identify metabolic coupling of calcium dependent ATP 
production could include in vitro assays such as defining a mitochondrial phenotype 
using SeaHorse XF. The proposed experiment could potentially identify how redox-
insensitive SERCA C674S reduces apoptosis in response to oxidative stress in vitro.   
Similarly, we could identify a metabolic phenotype in vivo using an IVIS Spectrum 
System before after pressure overload in SKI vs WT mice. 
The H2O2-stimulated increases in both SR calcium release and mitochondrial 
calcium concentration were attenuated in cells expressing the C674S mutant, suggesting 
that the decrease in basal SR content led to a decrease in the quantity of calcium available 
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for mitochondrial uptake.  Although this thesis focused on pathological ROS, it would be 
interesting to identify whether the reduction in ROS mediated mitochondrial calcium 
uptake in SERCA C674S is unfavorable during physiologic exercise.  To address this 
question one could subject WT and SKI mice to an exercise test in a metabolic chamber. 
It is possible for SKI mice to have reduced capacity for exercise due to their reduction in 
SR-mitochondrial calcium signaling.   
The proposed future research objectives would expand on thesis by identifying 
the mitochondrial phenotype associated with SERCA C674 oxidation.  These studies 
would potentially bridge the gap between SR-mitochondrial calcium signaling, 


















1.  Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha 
MJ, Cushman M, Das SR, de Ferranti S, Després J-P, Fullerton HJ, Howard VJ, 
Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, 
Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, 
Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, 
Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi 
A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart 
Association Statistics Committee, Stroke Statistics Subcommittee. Heart Disease 
and Stroke Statistics-2016 Update: A Report From the American Heart 
Association. Circulation [Internet]. 2016 [cited 2016 Aug 1];133:e38-60. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26673558 
2.  Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. 
Norepinephrine spillover to plasma in patients with congestive heart failure: 
evidence of increased overall and cardiorenal sympathetic nervous activity. 
[Internet]. 1986 [cited 2020 May 17]. Available from: 
https://www.ahajournals.org/doi/10.1161/01.CIR.73.4.615 
3.  de Lucia C, Eguchi A, Koch WJ. New insights in cardiac β-Adrenergic signaling 
during heart failure and aging. Frontiers in Pharmacology. 2018;9:904.  
4.  Lymperopoulos A, Rengo G, Koch WJ. Adrenergic Nervous System in Heart 
Failure. Circulation Research [Internet]. 2013 [cited 2020 May 17];113:739–753. 
Available from: 
https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.113.300308 
5.  Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, 
Semigran MJ, Dec GW, Khaw B-A. Apoptosis in Myocytes in End-Stage Heart 
Failure. New England Journal of Medicine [Internet]. 1996 [cited 2020 May 
17];335:1182–1189. Available from: 
http://www.nejm.org/doi/abs/10.1056/NEJM199610173351603 
6.  Oyama K, El-Nachef D, Maclellan WR. Regeneration potential of adult cardiac 
myocytes. Cell Research. 2013;23:978–979.  
7.  Madamanchi A. Beta-adrenergic receptor signaling in cardiac function and heart 
failure. McGill journal of medicine : MJM : an international forum for the 
advancement of medical sciences by students [Internet]. 2007 [cited 2017 Jan 
31];10:99–104. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18523538 
8.  Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS. H2O2 regulates 
cardiac myocyte phenotype via concentration-dependent activation of distinct 
66 
 
kinase pathways. Journal of Molecular and Cellular Cardiology [Internet]. 2003 
[cited 2018 Dec 17];35:615–621. Available from: 
https://www.sciencedirect.com/science/article/pii/S0022282803000841?via%3Dih
ub 
9.  Branco AF, Sampaio SF, Wieckowski MR, Sardão VA, Oliveira PJ. Mitochondrial 
disruption occurs downstream from β-adrenergic overactivation by isoproterenol in 
differentiated, but not undifferentiated H9c2 cardiomyoblasts: Differential 
activation of stress and survival pathways. The International Journal of 




10.  Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Singh K, 
Colucci WS. β-Adrenergic Receptor–Stimulated Apoptosis in Cardiac Myocytes Is 
Mediated by Reactive Oxygen Species/c-Jun NH2-Terminal Kinase–Dependent 
Activation of the Mitochondrial Pathway. Circulation Research. 2003;92.  
11.  Chen YR, Zweier JL. Cardiac mitochondria and reactive oxygen species 
generation. Circulation Research. 2014;114:524–537.  
12.  Murphy MP. How mitochondria produce reactive oxygen species. Biochemical 
Journal. 2009;417:1–13.  
13.  Hinchy EC, Gruszczyk A V, Willows R, Navaratnam N, Hall AR, Bates G, Bright 
TP, Krieg T, Carling D, Murphy MP. Mitochondria-derived ROS activate AMP-
activated protein kinase (AMPK) indirectly. The Journal of biological chemistry 
[Internet]. 2018 [cited 2019 Sep 10];293:17208–17217. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/30232152 
14.  Liddy KA, White MY, Cordwell SJ. Functional decorations: Post-translational 
modifications and heart disease delineated by targeted proteomics [Internet]. 
Genome Medicine. 2013 [cited 2020 May 18];5:20. Available from: 
http://genomemedicine.biomedcentral.com/articles/10.1186/gm424 
15.  Sivitz WI, Yorek MA. Mitochondrial dysfunction in diabetes: From molecular 
mechanisms to functional significance and therapeutic opportunities. Antioxidants 
and Redox Signaling. 2010;12:537–577.  
16.  Haas RH. Mitochondrial dysfunction in aging and diseases of aging. Biology. 
2019;8.  
17.  Dai D-F, Santana LF, Vermulst M, Tomazela DM, Emond MJ, MacCoss MJ, 
67 
 
Gollahon K, Martin GM, Loeb LA, Ladiges WC, Rabinovitch PS. Overexpression 
of Catalase Targeted to Mitochondria Attenuates Murine Cardiac Aging. 
Circulation [Internet]. 2009 [cited 2016 Jun 23];119:2789–2797. Available from: 
http://circ.ahajournals.org/cgi/doi/10.1161/CIRCULATIONAHA.108.822403 
18.  Ge W, Zhang Y, Han X, Ren J. Cardiac-Specific Overexpression of Catalase 
Attenuates Paraquat-Induced Myocardial Geometric and Contractile Alteration: 
Role of ER Stress. Free Radic Biol Med December. 2010;15:2068–2077.  
19.  Qin F, Siwik DA, Pimentel DR, Morgan RJ, Biolo A, Tu VH, Kang YJ, Cohen 
RA, Colucci WS, Adachi T, Matsui R, Xu S, Kirber M, Lazar H, Sharov V, 
Schoneich C, Cohen R, Adachi T, Weisbrod R, Pimentel D, Ying J, Sharov V, 
Schoneich C, Cohen R, Biolo A, Greferath R, Siwik D, Qin F, Valsky E, 
Fylaktakidou K, Pothukanuri S, Duarte C, Schwarz R, Lehn J, Nicolau C, Colucci 
W, Byrne J, Grieve D, Bendall J, Li J, Gove C, Lambeth J, Cave A, Shah A, 
D′Angelo D, Sakata Y, Lorenz J, Boivin G, Walsh R, Liggett S, Dorn G, Dai D, 
Hsieh E, Liu Y, Chen T, Beyer R, Chin M, MacCoss M, Rabinovitch P, Dai D, 
Johnson S, Villarin J, Chin M, Nieves-Cintron M, Chen T, Marcinek D, Dorn G, 
Kang Y, Prolla T, Santana L, Rabinovitch P, Date M, Morita T, Yamashita N, 
Nishida K, Yamaguchi O, Higuchi Y, Hirotani S, Matsumura Y, Hori M, Tada M, 
Otsu K, del M, Harding S, Schmidt U, Matsui T, Kang Z, Dec G, Gwathmey J, 
Rosenzweig A, Hajjar R, Ding B, Price R, Goldsmith E, Borg T, Yan X, Douglas 
P, Weinberg E, et al. Cytosolic H2O2 mediates hypertrophy, apoptosis, and 
decreased SERCA activity in mice with chronic hemodynamic overload. American 
journal of physiology Heart and circulatory physiology [Internet]. 2014 [cited 
2016 Jun 22];306:H1453-63. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/24633550 
20.  Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintrón M, Chen T, Marcinek 
DJ, Dorn GW, Kang YJ, Prolla TA, Santana LF, Rabinovitch PS. Mitochondrial 
oxidative stress mediates angiotensin II-induced cardiac hypertrophy and gαq 
overexpression-induced heart failure. Circulation Research. 2011;108:837–846.  
21.  Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, Cleland 
JGF, Colucci WS, Butler J, Voors AA, Anker SD, Pitt B, Pieske B, Filippatos G, 
Greene SJ, Gheorghiade M. Expert consensus document: Mitochondrial function 
as a therapeutic target in heart failure. Nature Reviews Cardiology. 2017;14:238–
250.  
22.  Ribeiro Junior RF, Dabkowski ER, Shekar KC, O’Connell KA, Hecker PA, 
Murphy MP. MitoQ improves mitochondrial dysfunction in heart failure induced 
by pressure overload. Free Radical Biology and Medicine. 2018;117:18–29.  
23.  Rossman MJ, Santos-Parker JR, Steward CAC, Bispham NZ, Cuevas LM, 
68 
 
Rosenberg HL, Woodward KA, Chonchol M, Gioscia-Ryan RA, Murphy MP, 
Seals DR. Chronic supplementation with a mitochondrial antioxidant (MitoQ) 
improves vascular function in healthy older adults. Hypertension [Internet]. 2018 
[cited 2020 May 31];71:1056–1063. Available from: 
https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.117.10787 
24.  Dey S, Sidor A, O’Rourke B. Compartment-specific Control of Reactive Oxygen 
Species Scavenging by Antioxidant Pathway Enzymes. The Journal of biological 
chemistry [Internet]. 2016 [cited 2019 Nov 25];291:11185–97. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/27048652 
25.  Birk A V, Chao WM, Bracken C, Warren JD, Szeto HH. Targeting mitochondrial 
cardiolipin and the cytochrome c/cardiolipin complex to promote electron 
transport and optimize mitochondrial ATP synthesis. British journal of 
pharmacology [Internet]. 2014 [cited 2020 May 30];171:2017–28. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/24134698 
26.  Dai DF, Chiao YA, Martin GM, Marcinek DJ, Basisty N, Quarles EK, Rabinovitch 
PS. Mitochondrial-Targeted Catalase: Extended Longevity and the Roles in 
Various Disease Models. In: Progress in Molecular Biology and Translational 
Science. Elsevier B.V.; 2017. p. 203–241. 
27.  Bertero E, Maack C. Calcium Signaling and Reactive Oxygen Species in 
Mitochondria. Circulation research [Internet]. 2018 [cited 2018 May 
14];122:1460–1478. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/29748369 
28.  Philippe R, Antigny F, Buscaglia P, Norez C, Becq F, Frieden M, Mignen O. 
SERCA and PMCA pumps contribute to the deregulation of Ca2+ homeostasis in 
human CF epithelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell 
Research [Internet]. 2015;1853:892–903. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0167488915000191 
29.  Lipskaia L, Keuylian Z, Blirando K, Mougenot N, Jacquet A, Rouxel C, Sghairi H, 
Elaib Z, Blaise R, Adnot S, Hajjar RJ, Chemaly ER, Limon I, Bobe R. Expression 
of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal 
mouse cardiovascular tissues, heart failure and atherosclerosis. Biochimica et 
Biophysica Acta - Molecular Cell Research. 2014;1843:2705–2718.  
30.  Dally S, Corvazier E, Bredoux R, Bobe R, Enouf J. Multiple and diverse 
coexpression, location, and regulation of additional SERCA2 and SERCA3 
isoforms in nonfailing and failing human heart. Journal of Molecular and Cellular 
Cardiology. 2010;48:633–644.  
69 
 
31.  Greene AL, Lalli MJ, Ji Y, Babu GJ, Grupp I, Sussman M, Periasamy M. 
Overexpression of SERCA2b in the heart leads to an increase in sarcoplasmic 
reticulum calcium transport function and increased cardiac contractility. Journal of 
Biological Chemistry. 2000;275:24722–24727.  
32.  Eisner D, Caldwell J, Trafford A. Sarcoplasmic reticulum Ca-ATPase and heart 
failure 20 years later. Circulation Research [Internet]. 2013 [cited 2020 May 
16];113:958–961. Available from: 
https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.113.302187 
33.  Ji Y, Lalli MJ, Babu GJ, Xu Y, Kirkpatrick DL, Liu LH, Chiamvimonvat N, 
Walsh RA, Shull GE, Periasamy M. Disruption of a Single Copy of the SERCA2 
Gene Results in Altered Ca 2؉ Homeostasis and Cardiomyocyte Function*. 
Published JBC Papers in Press [Internet]. 2000 [cited 2017 Aug 16];Available 
from: http://www.jbc.org/content/275/48/38073.full.pdf 
34.  Periasamy M, Reed TD, Liu LH, Ji Y, Loukianov E, Paul RJ, Nieman ML, Riddle 
T, Duffy JJ, Doetschman T, Lorenz JN, Shull GE. Impaired cardiac performance 
in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum 
Ca2+-ATPase isoform 2 (SERCA2) gene. Journal of Biological Chemistry. 
1999;274:2556–2562.  
35.  Schultz JEJ, Glascock BJ, Witt SA, Nieman ML, Nattamai KJ, Liu LH, Lorenz JN, 
Shull GE, Kimball TR, Periasamy M. Accelerated onset of heart failure in mice 
during pressure overload with chronically decreased SERCA2 calcium pump 
activity. American Journal of Physiology-Heart and Circulatory Physiology 
[Internet]. 2004 [cited 2020 May 17];286:H1146–H1153. Available from: 
https://www.physiology.org/doi/10.1152/ajpheart.00720.2003 
36.  Talukder MAH, Kalyanasundaram A, Zuo L, Velayutham M, Nishijima Y, 
Periasamy M, Zweier JL. Is reduced SERCA2a expression detrimental or 
beneficial to postischemic cardiac function and injury? Evidence from 
heterozygous SERCA2a knockout mice. American Journal of Physiology-Heart 
and Circulatory Physiology [Internet]. 2008 [cited 2020 May 17];294:H1426–
H1434. Available from: 
https://www.physiology.org/doi/10.1152/ajpheart.01016.2007 
37.  Li L, Louch WE, Niederer SA, Aronsen JM, Christensen G, Sejersted OM, Smith 
NP. Sodium Accumulation in SERCA Knockout-Induced Heart Failure. Biophysj 






38.  Land S, Louch WE, Niederer SA, Aronsen JM, Christensen G, Sjaastad I, 
Sejersted OM, Smith NP. Beta-adrenergic stimulation maintains cardiac function 
in Serca2 knockout Mice. Biophysical Journal. 2013;104:1349–1356.  
39.  Pan L, Huang B-J, Ma X-E, Wang S-Y, Feng J, Lv F, Liu Y, Liu Y, Li C-M, Liang 
D-D, Li J, Xu L, Chen Y-H. MiR-25 protects cardiomyocytes against oxidative 
damage by targeting the mitochondrial calcium uniporter. International journal of 
molecular sciences [Internet]. 2015 [cited 2017 Dec 11];16:5420–33. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/25764156 
40.  Meraviglia V, Bocchi L, Sacchetto R, Florio M, Motta B, Corti C, Weichenberger 
C, Savi M, D’Elia Y, Rosato-Siri M, Suffredini S, Piubelli C, Pompilio G, 
Pramstaller P, Domingues F, Stilli D, Rossini A. HDAC Inhibition Improves the 
Sarcoendoplasmic Reticulum Ca2+-ATPase Activity in Cardiac Myocytes. 
International Journal of Molecular Sciences [Internet]. 2018 [cited 2018 Feb 
6];19:419. Available from: http://www.mdpi.com/1422-0067/19/2/419 
41.  Park WJ, Oh JG. SERCA2a: a prime target for modulation of cardiac contractility 
during heart failure. BMB reports [Internet]. 2013 [cited 2018 Nov 28];46:237–43. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23710633 
42.  Pimentel D, Haeussler DJ, Matsui R, Burgoyne JR, Cohen RA, Bachschmid MM. 
Regulation of cell physiology and pathology by protein S-glutathionylation: 
Lessons learned from the cardiovascular system. Antioxidants and Redox 
Signaling. 2012;16:524–542.  
43.  Hagemann D, Xiao RP. Dual site phospholamban phosphorylation and its 
physiological relevance in the heart. Trends in Cardiovascular Medicine. 
2002;12:51–56.  
44.  Gustavsson M, Verardi R, Mullen DG, Mote KR, Traaseth NJ, Gopinath T, Veglia 
G. Allosteric regulation of SERCA by phosphorylationmediated conformational 
shift of phospholamban. Proceedings of the National Academy of Sciences of the 
United States of America. 2013;110:17338–17343.  
45.  Kuster GM, Lancel S, Zhang J, Communal C, Trucillo MP, Lim CC, Pfister O, 
Weinberg EO, Cohen RA, Liao R, Siwik DA, Colucci WS. Redox-mediated 
reciprocal regulation of SERCA and Na+–Ca2+ exchanger contributes to 
sarcoplasmic reticulum Ca2+ depletion in cardiac myocytes. Free Radical Biology 
and Medicine. 2010;48:1182–1187.  
46.  Lancel S, Zhang J, Evangelista A, Trucillo MP, Tong X, Siwik D a., Cohen R a., 
Colucci WS. Nitroxyl activates SERCA in cardiac myocytes via glutathiolation of 
cysteine 674. Circulation Research. 2009;104:720–723.  
71 
 
47.  Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schöneich C, Cohen 
RA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation 
by nitric oxide. Nature Medicine [Internet]. 2004 [cited 2016 Jun 22];10:1200–
1207. Available from: http://www.nature.com/doifinder/10.1038/nm1119 
48.  Qin F, Siwik DA, Lancel S, Zhang J, Kuster GM, Luptak I, Wang L, Tong X, 
Kang YJ, Cohen RA, Colucci WS. Hydrogen Peroxide-Mediated SERCA Cysteine 
674 Oxidation Contributes to Impaired Cardiac Myocyte Relaxation in Senescent 
Mouse Heart. Journal of the American Heart Association [Internet]. 2013 [cited 
2016 Jun 22];2:e000184–e000184. Available from: 
http://jaha.ahajournals.org/cgi/doi/10.1161/JAHA.113.000184 
49.  Thompson MD, Mei Y, Weisbrod RM, Silver M, Shukla PC, Bolotina VM, Cohen 
RA, Tong X. Glutathione adducts on sarcoplasmic/endoplasmic reticulum Ca2+ 
ATPase Cys-674 regulate endothelial cell calcium stores and angiogenic function 
as well as promote ischemic blood flow recovery. The Journal of biological 
chemistry [Internet]. 2014 [cited 2015 Aug 25];289:19907–16. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4106311&tool=pmcen
trez&rendertype=abstract 
50.  Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky 
A, Zsebo KM, Dittrich H, Hajjar RJ. Calcium upregulation by percutaneous 
administration of gene therapy in cardiac disease (CUPID): A phase 2 trial of 
intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients 
with advanced heart failure. Circulation. 2011;124:304–313.  
51.  Poganik JR, Long MJC, Aye Y. Interrogating Precision Electrophile Signaling. 
Trends in Biochemical Sciences [Internet]. 2019 [cited 2019 Mar 18];44:380–381. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/30765181 
52.  Poganik JR, Aye Y. Electrophile Signaling and Emerging Immuno- and Neuro-
modulatory Electrophilic Pharmaceuticals. Frontiers in Aging Neuroscience 
[Internet]. 2020 [cited 2020 May 18];12:1. Available from: 
https://www.frontiersin.org/article/10.3389/fnagi.2020.00001/full 
53.  Carafoli E. Historical review: Mitochondria and calcium: Ups and downs of an 
unusual relationship. Trends in Biochemical Sciences. 2003;28:175–181.  
54.  Tsien RY. New Calcium Indicators and Buffers with High Selectivity Against 
Magnesium and Protons: Design, Synthesis, and Properties of Prototype 
Structures. Biochemistry. 1980;19:2396–2404.  
55.  Filippin L, Abad MC, Gastaldello S, Magalhães PJ, Sandonà D, Pozzan T. 
Improved strategies for the delivery of GFP-based Ca2+ sensors into the 
72 
 
mitochondrial matrix. Cell calcium [Internet]. 2005 [cited 2015 Nov 19];37:129–
36. Available from: 
http://www.sciencedirect.com/science/article/pii/S0143416004001368 
56.  Kaestner L, Scholz A, Tian Q, Ruppenthal S, Tabellion W, Wiesen K, Katus HA, 
Muller OJ, Kotlikoff MI, Lipp P. Genetically Encoded Ca2+ Indicators in Cardiac 
Myocytes. Circulation Research [Internet]. 2014 [cited 2016 Sep 1];114:1623–
1639. Available from: 
http://circres.ahajournals.org/cgi/doi/10.1161/CIRCRESAHA.114.303475 
57.  Chen TW, Wardill TJ, Sun Y, Pulver SR, Renninger SL, Baohan A, Schreiter ER, 
Kerr RA, Orger MB, Jayaraman V, Looger LL, Svoboda K, Kim DS. 
Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature. 
2013;499:295–300.  
58.  Nakai J, Ohkura M, Imoto K. A high signal-to-noise ca2+ probe composed of a 
single green fluorescent protein. Nature Biotechnology. 2001;19:137–141.  
59.  Tallini YM, Ohkura M, Choi BR, Ji G, Imoto K, Doran R, Lee J, Plan P, Wilson J, 
Xin HB, Sanbe A, Gulick J, Mathai J, Robbins J, Salama G, Nakai J, Kotlikoff MI. 
Imaging cellular signals in the heart in vivo: Cardiac expression of the high-signal 
Ca2+ indicator GCaMP2. Proceedings of the National Academy of Sciences of the 
United States of America. 2006;103:4753–4758.  
60.  Horikawa K, Yamada Y, Matsuda T, Kobayashi K, Hashimoto M, Matsu-ura T, 
Miyawaki A, Michikawa T, Mikoshiba K, Nagai T. Spontaneous network activity 
visualized by ultrasensitive Ca2+ indicators, yellow Cameleon-Nano. Nature 
Methods [Internet]. 2010 [cited 2016 Aug 23];7:729–732. Available from: 
http://www.nature.com/doifinder/10.1038/nmeth.1488 
61.  Hendel T, Mank M, Schnell B, Griesbeck O, Borst A, Reiff DF. Fluorescence 
Changes of Genetic Calcium Indicators and OGB-1 Correlated with Neural 
Activity and Calcium In Vivo and In Vitro. Journal of Neuroscience [Internet]. 
2008 [cited 2019 Feb 4];28:7399–7411. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/18632944 
62.  Oh J, Lee C, Kaang B-K. Imaging and analysis of genetically encoded calcium 
indicators linking neural circuits and behaviors. The Korean Journal of Physiology 
& Pharmacology [Internet]. 2019 [cited 2020 May 26];23:237. Available from: 
https://synapse.koreamed.org/DOIx.php?id=10.4196/kjpp.2019.23.4.237 
63.  Finkel T, Menazza S, Holmstrom KM, Parks RJ, Liu J, Sun J, Liu J, Pan X, 
Murphy E. The Ins and Outs of Mitochondrial Calcium. Circulation Research 




64.  Williams GSB, Boyman L, Lederer WJ. Mitochondrial calcium and the regulation 
of metabolism in the heart. Journal of Molecular and Cellular Cardiology 




65.  Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher-Timme CA, Sancak 
Y, Bao XR, Strittmatter L, Goldberger O, Bogorad RL, Koteliansky V, Mootha 
VK. Integrative genomics identifies MCU as an essential component of the 
mitochondrial calcium uniporter. Nature. 2011;476:341–345.  
66.  De Stefani D, Raffaello A, Teardo E, Szabó I, Rizzuto R. A forty-kilodalton 
protein of the inner membrane is the mitochondrial calcium uniporter. Nature. 
2011;476:336–340.  
67.  Dong Z, Shanmughapriya S, Tomar D, Siddiqui N, Lynch S, Nemani N, Breves 
SL, Zhang X, Tripathi A, Palaniappan P, Riitano MF, Worth AM, Seelam A, 
Carvalho E, Subbiah R, Jaña F, Soboloff J, Peng Y, Cheung JY, Joseph SK, 
Caplan J, Rajan S, Stathopulos PB, Madesh M. Mitochondrial Ca2+ Uniporter Is a 
Mitochondrial Luminal Redox Sensor that Augments MCU Channel Activity. 
Molecular cell [Internet]. 2017 [cited 2018 Jun 27];65:1014-1028.e7. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/28262504 
68.  Luongo TS, Lambert JP, Yuan A, Zhang X, Gross P, Song J, Shanmughapriya S, 
Gao E, Jain M, Houser SR, Koch WJ, Cheung JY, Madesh M, Elrod JW. The 
Mitochondrial Calcium Uniporter Matches Energetic Supply with Cardiac 
Workload during Stress and Modulates Permeability Transition. Cell Reports 
[Internet]. 2015;12:23–34. Available from: 
http://www.cell.com/article/S2211124715006154/fulltext 
69.  Beutner G, Sharma VK, Lin L, Ryu S-Y, Dirksen RT, Sheu S-S. Type 1 ryanodine 
receptor in cardiac mitochondria: Transducer of excitation–metabolism coupling. 
Biochimica et Biophysica Acta (BBA) - Biomembranes. 2005;1717:1–10.  
70.  Konstantinidis K, Lederer WJ, Rizzuto R, Kitsis RN. Mitofusin 2 joins the 
sarcoplasmic reticulum and mitochondria at the hip to sustain cardiac energetics. 
Circulation research [Internet]. 2012 [cited 2016 Oct 28];111:821–3. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/22982869 
71.  Kwong JQ. The mitochondrial calcium uniporter in the heart: energetics and 
beyond. The Journal of Physiology [Internet]. 2017 [cited 2019 Feb 18];595:3743–
74 
 
3751. Available from: http://doi.wiley.com/10.1113/JP273059 
72.  Denton RM. Regulation of mitochondrial dehydrogenases by calcium ions. 
Biochimica et Biophysica Acta - Bioenergetics. 2009;1787:1309–1316.  
73.  Jouaville LS, Pinton P, Bastianutto C, Rutter GA, Rizzuto R. Regulation of 
mitochondrial ATP synthesis by calcium: Evidence for a long-term metabolic 
priming. Proceedings of the National Academy of Sciences of the United States of 
America. 1999;96:13807–13812.  
74.  De La Fuente S, Lambert JP, Nichtova Z, Fernandez Sanz C, Elrod JW, Sheu S-S, 
Csordás G. Spatial Separation of Mitochondrial Calcium Uptake and Extrusion for 
Energy-Efficient Mitochondrial Calcium Signaling in the Heart. Cell reports 
[Internet]. 2018 [cited 2018 Sep 25];24:3099-3107.e4. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/30231993 
75.  Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the 
normal and failing heart. Physiological Reviews. 2005;85:1093–1129.  
76.  Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure: Implications 
beyond atp production. Circulation Research. 2013;113:709–724.  
77.  Cabassi A, Miragoli M. Altered Mitochondrial Metabolism and Mechanosensation 
in the Failing Heart: Focus on Intracellular Calcium Signaling. International 
Journal of Molecular Sciences [Internet]. 2017 [cited 2019 Nov 11];18:1487. 
Available from: http://www.mdpi.com/1422-0067/18/7/1487 
78.  Santulli G, Xie W, Reiken SR, Marks AR. Mitochondrial calcium overload is a 
key determinant in heart failure. Proceedings of the National Academy of Sciences 
[Internet]. 2015 [cited 2016 Jun 22];112:11389–11394. Available from: 
http://www.pnas.org/lookup/doi/10.1073/pnas.1513047112 
79.  Kwong JQ, Molkentin JD. Physiological and Pathological Roles of the 
Mitochondrial Permeability Transition Pore in the Heart. Cell Metabolism. 
2015;21:206–214.  
80.  Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, 
Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Bobbins J, Molkentin JD. Loss 
of cyclophilin D reveals a critical role for mitochondrial permeability transition in 
cell death. Nature. 2005;434:658–662.  
81.  Gordan R, Fefelova N, Gwathmey JK, Xie LH. Involvement of mitochondrial 
permeability transition pore (mPTP) in cardiac arrhythmias: Evidence from 
cyclophilin D knockout mice. Cell Calcium. 2016;60:363–372.  
75 
 
82.  Connern CP, Halestrap AP. Recruitment of mitochondrial cyclophilin to the 
mitochondrial inner membrane under conditions of oxidative stress that enhance 
the opening of a calcium-sensitive non-specific channel. Biochemical Journal. 
1994;302:321–324.  
83.  Briston T, Roberts M, Lewis S, Powney B, Staddon JM, Szabadkai G, Duchen 
MR. Mitochondrial permeability transition pore: Sensitivity to opening and 
mechanistic dependence on substrate availability. Scientific Reports. 2017;7.  
84.  Kim NH, Kang PM. Apoptosis in cardiovascular diseases: Mechanism and clinical 
implications. Korean Circulation Journal. 2010;40:299–305.  
85.  Rossi A, Pizzo P, Filadi R. Calcium, mitochondria and cell metabolism: A 
functional triangle in bioenergetics. Biochimica et Biophysica Acta (BBA) - 




86.  Eisner V, Csordás G, Hajnóczky G. Interactions between sarco-endoplasmic 
reticulum and mitochondria in cardiac and skeletal muscle – pivotal roles in Ca2+ 
and reactive oxygen species signaling. Journal of Cell Science. 2013;126.  
87.  Chen Y, Csordás G, Jowdy C, Schneider TG, Csordás N, Wang W, Liu Y, 
Kohlhaas M, Meiser M, Bergem S, Nerbonne JM, Dorn GW, Maack C. Mitofusin 
2-containing mitochondrial-reticular microdomains direct rapid cardiomyocyte 
bioenergetic responses via interorganelle Ca2+ crosstalk. Circulation Research. 
2012;111:863–875.  
88.  De La Fuente S, Fernandez-Sanz C, Vail C, Agra EJ, Holmstrom K, Sun J, Mishra 
J, Williams D, Finkel T, Murphy E, Joseph SK, Sheu S-S, Csordás G. Strategic 
Positioning and Biased Activity of the Mitochondrial Calcium Uniporter in 
Cardiac Muscle. The Journal of biological chemistry [Internet]. 2016 [cited 2016 
Nov 28];291:23343–23362. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/27637331 
89.  van Vliet AR, Verfaillie T, Agostinis P. New functions of mitochondria associated 
membranes in cellular signaling. Biochimica et Biophysica Acta (BBA) - 
Molecular Cell Research [Internet]. 2014 [cited 2018 Jan 30];1843:2253–2262. 
Available from: 
https://www.sciencedirect.com/science/article/pii/S0167488914000937 
90.  Eisner V, Csordas G, Hajnoczky G. Interactions between sarco-endoplasmic 
reticulum and mitochondria in cardiac and skeletal muscle - pivotal roles in 
76 
 
Ca(2)(+) and reactive oxygen species signaling. Journal of cell science [Internet]. 
2013;126:2965–2978. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/23843617%5Cnhttp://jcs.biologists.org/cont
ent/joces/126/14/2965.full.pdf 
91.  Chen Y, Csordás G, Jowdy C, Schneider TG, Csordás N, Wang W, Liu Y, 
Kohlhaas M, Meiser M, Bergem S, Nerbonne JM, Dorn GW, Maack C, Maack C. 
Mitofusin 2-containing mitochondrial-reticular microdomains direct rapid 
cardiomyocyte bioenergetic responses via interorganelle Ca(2+) crosstalk. 
Circulation research [Internet]. 2012 [cited 2019 Nov 11];111:863–75. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/22777004 
92.  Papanicolaou KN, Khairallah RJ, Ngoh GA, Chikando A, Luptak I, O’Shea KM, 
Riley DD, Lugus JJ, Colucci WS, Lederer WJ, Stanley WC, Walsh K. Mitofusin-2 
maintains mitochondrial structure and contributes to stress-induced permeability 
transition in cardiac myocytes. Molecular and cellular biology [Internet]. 2011 
[cited 2017 Jul 20];31:1309–28. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/21245373 
93.  Harr MW, Distelhorst CW. Apoptosis and autophagy: decoding calcium signals 
that mediate life or death. Cold Spring Harbor perspectives in biology [Internet]. 
2010 [cited 2017 Jun 28];2:a005579. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20826549 
94.  Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors and 
regulators of calcium signalling. Nature Reviews Molecular Cell Biology 
[Internet]. 2012 [cited 2016 Oct 18];13:566–578. Available from: 
http://www.nature.com/doifinder/10.1038/nrm3412 
95.  Seidlmayer LK, Kuhn J, Berbner A, Arias-Loza P-A, Williams T, Kaspar M, 
Czolbe M, Kwong JQ, Molkentin JD, Heinze KG, Dedkova EN, Ritter O. Inositol 
1,4,5-trisphosphate-mediated sarcoplasmic reticulum-mitochondrial crosstalk 
influences adenosine triphosphate production via mitochondrial Ca 21 uptake 
through the mito-chondrial ryanodine receptor in cardiac myocytes. [cited 2020 
May 26];Available from: https://academic.oup.com/cardiovascres/article-
abstract/112/1/491/2469957 
96.  Seidlmayer LK, Mages C, Berbner A, Eder-Negrin P, Arias-Loza PA, Kaspar M, 
Song M, Dorn GW, Kohlhaas M, Frantz S, Maack C, Gerull B, Dedkova EN, 
Dedkova EN. Mitofusin 2 Is Essential for IP3-Mediated SR/Mitochondria 
Metabolic Feedback in Ventricular Myocytes. Frontiers in physiology [Internet]. 




97.  Ruiz-Meana M, Fernandez-Sanz C, Garcia-Dorado D, Lisa F Di, Blank P, Colonna 
R, Gambassi G, Silverman H, Stern M, Brand M, Buckingham J, Esteves T, Green 
K, Lambert A, Miwa S, Zima A, Blatter L, Yoshida T, Maulik N, Engelman R, Ho 
Y, Das D, Speakman J, Talbot D, Selman C, Snart S, McLaren J, Redman P, 
Carafoli E, Lehninger A, Carafoli E, Rossi C, Lehninger A, Rizzuto R, Bernardi P, 
Pozzan T, Saotome M, Katoh H, Satoh H, Nagasaka S, Yoshihara S, Terada H, 
Montero M, Alonso M, Albillos A, Garcia-Sancho J, Alvarez J, Gunter T, Gunter 
K, Sheu S, Gavin C, Bernardi P, Petronilli V, Ichas F, Jouaville L, Mazat J, 
McCormack J, Halestrap A, Denton R, Scorrano L, Oakes S, Opferman J, Cheng 
E, Sorcinelli M, Pozzan T, Nakayama H, Chen X, Baines C, Klevitsky R, Zhang 
X, Zhang H, Halestrap A, Boitier E, Rea R, Duchen M, Babcock D, Herrington J, 
Goodwin P, Park Y, Hille B, Aon M, Cortassa S, Marban E, O’Rourke B, Maack 
C, Dabew E, Hohl M, Schafers H, Bohm M, Murata M, Akao M, O’Rourke B, 
Marban E, Xu W, Liu Y, Wang S, McDonald T, Eyk J Van, et al. The SR-
mitochondria interaction: a new player in cardiac pathophysiology. 
Cardiovascular research [Internet]. 2010 [cited 2016 Aug 9];88:30–9. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/20615915 
98.  Fernandez-Sanz C, Ruiz-Meana M, Miro-Casas E, Nuñez E, Castellano J, Loureiro 
M, Barba I, Poncelas M, Rodriguez-Sinovas A, Vázquez J, Garcia-Dorado D. 
Defective sarcoplasmic reticulum-mitochondria calcium exchange in aged mouse 
myocardium. Cell Death and Disease. 2014;5:e1573–e1573.  
99.  Eisner V, Cupo RR, Gao E, Csordás G, Slovinsky WS, Paillard M, Cheng L, Ibetti 
J, Chen SRW, Chuprun JK, Hoek JB, Koch WJ, Hajnóczky G. Mitochondrial 
fusion dynamics is robust in the heart and depends on calcium oscillations and 
contractile activity. Proceedings of the National Academy of Sciences of the United 
States of America [Internet]. 2017 [cited 2017 Feb 15];114:E859–E868. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/28096338 
100.  Xu Z, Zhang D, He X, Huang Y, Shao H. Transport of Calcium Ions into 
Mitochondria. Current Genomics. 2016;17:215–219.  
101.  Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-
induced mitochondrial toxicity and synaptic damage in Huntington’s disease 
[Internet]. [cited 2020 May 30];Available from: 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986329/ 
102.  Mourier A, Motori E, Brandt T, Lagouge M, Atanassov I, Galinier A, Rappl G, 
Brodesser S, Hultenby K, Dieterich C, Larsson NG. Mitofusin 2 is required to 
maintain mitochondrial coenzyme Q levels. Journal of Cell Biology. 
2015;208:429–442.  
103.  Tantama M, Martínez-François JR, Mongeon R, Yellen G. Imaging energy status 
78 
 
in live cells with a fluorescent biosensor of the intracellular ATP-to-ADP ratio. 
Nature Communications [Internet]. 2013 [cited 2019 Sep 3];4:2550. Available 
from: http://www.nature.com/articles/ncomms3550 
104.  Ying J, Tong X, Pimentel DR, Weisbrod RM, Trucillo MP, Adachi T, Cohen RA. 
Cysteine-674 of the Sarco/Endoplasmic Reticulum Calcium ATPase Is Required 
for the Inhibition of Cell Migration by Nitric Oxide. Arteriosclerosis, Thrombosis, 
and Vascular Biology [Internet]. 2007 [cited 2016 Jun 22];27:783–790. Available 
from: http://atvb.ahajournals.org/cgi/doi/10.1161/01.ATV.0000258413.72747.23 
105.  Palmer AE, Giacomello M, Kortemme T, Hires SA, Lev-Ram V, Baker D, Tsien 
RY. Ca2+ indicators based on computationally redesigned calmodulin-peptide 
pairs. Chemistry & biology [Internet]. 2006 [cited 2015 Oct 28];13:521–30. 
Available from: 
http://www.sciencedirect.com/science/article/pii/S1074552106001177 
106.  Luptak I, Morgan R, Baka T, Croteau D, Moverman D, Sarnak H, Kirber M, 
Bachschmid MM, Colucci WS, Pimentel DR. Genetically targeted fluorescent 
probes reveal dynamic calcium responses to adrenergic signaling in multiple 
cardiomyocyte compartments. The International Journal of Biochemistry & Cell 
Biology [Internet]. 2019 [cited 2019 Nov 25];114:105569. Available from: 
https://www.sciencedirect.com/science/article/pii/S1357272519301463?via%3Dih
ub 
107.  Vellekamp G, Porter FW, Sutjipto S, Cutler C, Bondoc L, Liu Y-H, Wylie D, 
Cannon-Carlson S, Tang JT, Frei A, Voloch M, Zhuang S. Empty Capsids in 
Column-Purified Recombinant Adenovirus Preparations. Human Gene Therapy 
[Internet]. 2001 [cited 2020 May 17];12:1923–1936. Available from: 
http://www.liebertpub.com/doi/10.1089/104303401753153974 
108.  Kranias EG, Hajjar RJ. Modulation of cardiac contractility by the 
phopholamban/SERCA2a regulatome. Circulation Research [Internet]. 2012 [cited 
2020 May 17];110:1646–1660. Available from: 
https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.111.259754 
109.  Lancel S, Qin F, Lennon SL, Zhang J, Tong X, Mazzini MJ, Kang YJ, Siwik DA, 
Cohen RA, Colucci WS. Oxidative posttranslational modifications mediate 
decreased SERCA activity and myocyte dysfunction in Galphaq-overexpressing 




110.  Rossi A, Pizzo P, Filadi R. Calcium, mitochondria and cell metabolism: A 
79 
 
functional triangle in bioenergetics. Biochimica et Biophysica Acta - Molecular 
Cell Research. 2019;1866:1068–1078.  
111.  O’Rourke B, Blatter LA. Mitochondrial Ca2+ uptake: Tortoise or hare? Journal of 
Molecular and Cellular Cardiology. 2009;46:767–774.  
112.  Ljubojević S, Walther S, Asgarzoei M, Sedej S, Pieske B, Kockskämper J. In situ 
calibration of nucleoplasmic versus cytoplasmic Ca2+ concentration in adult 
cardiomyocytes. Biophysical Journal. 2011;100:2356–2366.  
113.  Genetic calcium detector [Internet]. [cited 2020 May 25];Available from: 
http://health-abstracts.com/n/neuronet.jp1.html 
114.  Mallilankaraman K, Doonan P, sar Cá rdenas C, Chandramoorthy HC, Mü ller M, 
Miller R, Hoffman NE, Kumar Gandhirajan R, Molgó J, Birnbaum MJ, Rothberg 
BS, Daniel Mak D-O, Kevin Foskett J, Madesh M. MICU1 Is an Essential 
Gatekeeper for MCU-Mediated Mitochondrial Ca 2+ Uptake that Regulates Cell 
Survival. Cell [Internet]. 2012 [cited 2017 Mar 7];151:630–644. Available from: 
http://dx.doi.org/10.1016/j.cell.2012.10.011 
115.  Ying J, Sharov V, Xu S, Jiang B, Gerrity R, Schöneich C, Cohen RA. Cysteine-
674 oxidation and degradation of sarcoplasmic reticulum Ca 2+ ATPase in 




116.  Wei AC, Liu T, Winslow RL, O’Rourke B. Dynamics of matrix-free Ca2+ in 
cardiac mitochondria: Two components of Ca2+ uptake and role of phosphate 
buffering. Journal of General Physiology. 2012;139:465–478.  
117.  Finkel T, Menazza S, Holmström KM, Parks RJ, Liu J, Sun J, Liu J, Pan X, 
Murphy E. The Ins and Outs of Mitochondrial Calcium. Circulation Research. 
2015;116.  
118.  Gensch T, Kaschuba D. Fluorescent Genetically Encoded Calcium Indicators and 
Their In Vivo Application. Springer, Berlin, Heidelberg; 2011. p. 125–161. 
119.  Hendel T, Mank M, Schnell B, Griesbeck O, Borst A, Reiff DF. Fluorescence 
changes of genetic calcium indicators and OGB-1 correlated with neural activity 
and calcium in vivo and in vitro. Journal of Neuroscience. 2008;28:7399–7411.  
120.  Thomas D, Tovey SC, Collins TJ, Bootman MD, Berridge MJ, Lipp P. A 
comparison of fluorescent Ca2+ indicator properties and their use in measuring 
80 
 
elementary and global Ca2+ signals. Cell Calcium. 2000;28:213–223.  
121.  Wüst RCI, Helmes M, Martin JL, van der Wardt TJT, Musters RJP, van der 
Velden J, Stienen GJM. Rapid frequency-dependent changes in free mitochondrial 
calcium concentration in rat cardiac myocytes. The Journal of Physiology 
[Internet]. 2017 [cited 2017 Mar 14];Available from: 
http://doi.wiley.com/10.1113/JP273589 
122.  Greotti E, Fortunati I, Pendin D, Ferrante C, Galla L, Zentilin L, Giacca M, 
Kaludercic N, Di Sante M, Mariotti L, Lia A, Gómez-Gonzalo M, Sessolo M, 
Carmignoto G, Bozio R, Pozzan T. mCerulean3-Based Cameleon Sensor to 
Explore Mitochondrial Ca2+ Dynamics In Vivo. iScience. 2019;16:340–355.  
123.  Beaver JP, Waring P. Thapsigargin induces mitochondrial dysfunction and 
apoptosis in the mastocytoma P815 cell line and in mouse thymocytes. Cell death 
and differentiation [Internet]. 1996 [cited 2016 Jun 14];3:415–24. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/17180112 
124.  Chen X, Zhang X, Kubo H, Harris DM, Mills GD, Moyer J, Berretta R, Potts ST, 
Marsh JD, Houser SR. Ca2+ Influx–Induced Sarcoplasmic Reticulum Ca2+ 
Overload Causes Mitochondrial-Dependent Apoptosis in Ventricular Myocytes. 
Circulation Research. 2005;97.  
125.  Beutner G, Sharma VK, Lin L, Ryu S-Y, Dirksen RT, Sheu S-S. Type 1 ryanodine 
receptor in cardiac mitochondria: Transducer of excitation–metabolism coupling. 
Biochimica et Biophysica Acta (BBA) - Biomembranes [Internet]. 2005 [cited 2019 
Mar 7];1717:1–10. Available from: 
https://www.sciencedirect.com/science/article/pii/S0005273605002981?via%3Dih
ub 
126.  Bround MJ, Wambolt R, Cen H, Asghari P, Albu RF, Han J, McAfee D, Pourrier 
M, Scott NE, Bohunek L, Kulpa JE, Chen SRW, Fedida D, Brownsey RW, 
Borchers CH, Foster LJ, Mayor T, Moore EDW, Allard MF, Johnson JD. Cardiac 
Ryanodine Receptor (Ryr2)-mediated Calcium Signals Specifically Promote 
Glucose Oxidation via Pyruvate Dehydrogenase. The Journal of biological 
chemistry [Internet]. 2016 [cited 2019 Oct 11];291:23490–23505. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/27621312 
127.  Hamilton J, Brustovetsky T, Rysted JE, Lin Z, Usachev YM, Brustovetsky N. 
Deletion of mitochondrial calcium uniporter incompletely inhibits calcium uptake 
and induction of the permeability transition pore in brain mitochondria. The 
Journal of biological chemistry [Internet]. 2018 [cited 2019 Jan 21];293:15652–
15663. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30154242 
81 
 
128.  Bhagavan NV, Ha C-E, Bhagavan NV, Ha C-E. Carbohydrate Metabolism I: 
Glycolysis and the Tricarboxylic Acid Cycle. Essentials of Medical Biochemistry 




129.  Berg J, Hung YP, Yellen G. A genetically encoded fluorescent reporter of 
ATP:ADP ratio. Nature methods [Internet]. 2009 [cited 2019 Sep 3];6:161–6. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19122669 
130.  Chikando AC, Kettlewell S, Williams GS, Smith G, Lederer WJ. Ca2+ dynamics 
in the mitochondria - state of the art. Journal of molecular and cellular cardiology 
[Internet]. 2011 [cited 2016 May 24];51:627–31. Available from: 
http://www.sciencedirect.com/science/article/pii/S002228281100321X 
131.  Wei A-C, Liu T, O’Rourke B. Dual Effect of Phosphate Transport on 
Mitochondrial Ca2+ Dynamics. The Journal of biological chemistry [Internet]. 
2015 [cited 2017 Mar 7];290:16088–98. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/25963147 
132.  Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS, 
Babenko VA, Zorov SD, Balakireva A V., Juhaszova M, Sollott SJ, Zorov DB. 
Mitochondrial membrane potential. Analytical Biochemistry. 2018;552:50–59.  
133.  Webster KA. Mitochondrial membrane permeabilization and cell death during 
myocardial infarction: Roles of calcium and reactive oxygen species. Future 
Cardiology. 2012;8:863–884.  
134.  Goto K, Takemura G, Maruyama R, Nakagawa M, Tsujimoto A, Kanamori H, Li 
L, Kawamura I, Kawaguchi T, Takeyama T, Fujiwara H, Minatoguchi S. Unique 
mode of cell death in freshly isolated adult rat ventricular cardiomyocytes exposed 
to hydrogen peroxide. Medical Molecular Morphology. 2009;42:92–101.  
135.  Parks RJ, Menazza S, Holmströ M 2 † KM, Amanakis G, Fergusson M, Ma H, 
Aponte AM, Bernardi P, Finkel T, Murphy E. Cyclophilin D-mediated regulation 
of the permeability transition pore is altered in mice lacking the mitochondrial 
calcium uniporter.  
136.  De Jesús García-Rivas G, Guerrero-Hernández A, Guerrero-Serna G, Rodríguez-
Zavala JS, Zazueta C. Inhibition of the mitochondrial calcium uniporter by the 
oxo-bridged dinuclear ruthenium amine complex (Ru360) prevents from 
irreversible injury in postischemic rat heart. FEBS Journal [Internet]. 2005 [cited 




137.  Ke H ‐Y., Yang H ‐Y., Francis AJ, Collins TP, Surendran H, Alvarez‐Laviada A, 
Firth JM, MacLeod KT. Changes in cellular Ca 2+ and Na + regulation during the 
progression towards heart failure in the guinea pig. The Journal of Physiology 
[Internet]. 2019 [cited 2019 Jul 3];JP277038. Available from: 
https://onlinelibrary.wiley.com/doi/abs/10.1113/JP277038 
138.  Kuo TH, Zhu L, Golden K, Marsh JD, Bhattacharya SK, Liu B-F. Altered Ca2+ 
homeostasis and impaired mitochondrial function in cardiomyopathy. Molecular 
and cellular biochemistry [Internet]. 2002 [cited 2020 May 4];238:119–27. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12349899 
139.  Bonora M, Morganti C, Morciano G, Pedriali G, Lebiedzinska‐Arciszewska M, 
Aquila G, Giorgi C, Rizzo P, Campo G, Ferrari R, Kroemer G, Wieckowski MR, 
Galluzzi L, Pinton P.  Mitochondrial permeability transition involves dissociation 
of F 1  F O ATP  synthase dimers and C‐ring conformation . EMBO reports. 
2017;18:1077–1089.  
140.  Lu X, Kwong JQ, Molkentin JD, Bers DM. Individual cardiac mitochondria 
undergo rare transient permeability transition pore openings. Circulation Research 
[Internet]. 2016 [cited 2020 May 18];118:834–841. Available from: 
https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.115.308093 
141.  Elrod JW, Wong R, Mishra S, Vagnozzi RJ, Sakthievel B, Goonasekera SA, Karch 
J, Gabel S, Farber J, Force T, Brown JH, Murphy E, Molkentin JD. Cyclophilin D 
controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and 
propensity for heart failure in mice. The Journal of clinical investigation [Internet]. 
2010 [cited 2017 Mar 7];120:3680–7. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20890047 
142.  Ichas F, Jouaville LS, Mazat JP. Mitochondria are excitable organelles capable of 
generating and conveying electrical and calcium signals. Cell. 1997;89:1145–
1153.  
143.  Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species 
(ROS)-induced ROS release: a new phenomenon accompanying induction of the 
mitochondrial permeability transition in cardiac myocytes. The Journal of 
experimental medicine [Internet]. 2000 [cited 2019 Jul 9];192:1001–14. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/11015441 
144.  Duan Z-Z, Li Y-H, Li Y-Y, Fan G-W, Chang Y-X, Yu B, Gao X-M. Danhong 
injection protects cardiomyocytes against hypoxia/reoxygenation- and H2O2-
induced injury by inhibiting mitochondrial permeability transition pore opening. 
83 
 
Journal of Ethnopharmacology. 2015;175:617–625.  
145.  Brookes PS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. AJP: 
Cell Physiology [Internet]. 2004 [cited 2016 Sep 28];287:C817–C833. Available 
from: http://ajpcell.physiology.org/cgi/doi/10.1152/ajpcell.00139.2004 
146.  Yaniv Y, Juhaszova M, Nuss HB, Wang S, Zorov DB, Lakatta EG, Sollott SJ. 
Matching ATP Supply and Demand in Mammalian Heart: In Vivo, In Vitro and In 
Silico Perspectives.  
147.  Guimarães-Ferreira L. Role of the phosphocreatine system on energetic 
homeostasis in skeletal and cardiac muscles. Einstein (São Paulo, Brazil). 
2014;12:126–131.  
148.  Giorgi C, Marchi S, Pinton P. The machineries, regulation and cellular functions of 
mitochondrial calcium. Nature Reviews Molecular Cell Biology. 2018;19:713–
730.  
149.  Bernardi P, von Stockum S. The permeability transition pore as a Ca2+ release 














 CURRICULUM VITAE 
85 
 
  
 
86 
 
 
87 
 
88 
 
